{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:57:35Z","timestamp":1791122255949,"version":"4.1.0"},"reference-count":332,"publisher":"Springer Science and Business Media LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Immunopathol"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s00281-009-0164-5","type":"journal-article","created":{"date-parts":[[2009,7,14]],"date-time":"2009-07-14T14:20:02Z","timestamp":1247581202000},"page":"283-307","source":"Crossref","is-referenced-by-count":147,"title":["Primary biliary cirrhosis"],"prefix":"10.1007","volume":"31","author":[{"given":"Simon","family":"Hohenester","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald P. J.","family":"Oude-Elferink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Beuers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,7,15]]},"reference":[{"issue":"12","key":"164_CR1","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","volume":"353","author":"MM Kaplan","year":"2005","unstructured":"Kaplan MM, Gershwin ME (2005) Primary biliary cirrhosis. N Engl J Med 353(12):1261\u20131273. doi: 10.1056\/NEJMra043898","journal-title":"N Engl J Med"},{"key":"164_CR2","first-page":"G265","volume":"7","author":"T Addison","year":"1851","unstructured":"Addison T, Gull W (1851) On a certain affection of the skin-vitiligoidea-\u03b1-plana \u03b2-tuberosa. Guys Hosp Rep 7:G265\u2013G277","journal-title":"Guys Hosp Rep"},{"issue":"6, Pt. 2","key":"164_CR3","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1172\/JCI102222","volume":"28","author":"EH Ahrens Jr","year":"1949","unstructured":"Ahrens EH Jr, Kunkel HG (1949) The relationship between serum lipids and skin xanthomata in 18 patients with primary biliary cirrhosis. J Clin Invest 28(6, Pt. 2):1565\u20131574. doi: 10.1172\/JCI102222","journal-title":"J Clin Invest"},{"issue":"3","key":"164_CR4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1055\/s-2002-34506","volume":"22","author":"A Nishio","year":"2002","unstructured":"Nishio A, Keeffe EB, Gershwin ME (2002) Immunopathogenesis of primary biliary cirrhosis. Semin Liver Dis 22(3):291\u2013302. doi: 10.1055\/s-2002-34506","journal-title":"Semin Liver Dis"},{"key":"164_CR5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1034\/j.1600-0528.2002.00021h.x","volume":"174","author":"SJ Yeaman","year":"2000","unstructured":"Yeaman SJ, Kirby JA, Jones DE (2000) Autoreactive responses to pyruvate dehydrogenase complex in the pathogenesis of primary biliary cirrhosis. Immunol Rev 174:238\u2013249. doi: 10.1034\/j.1600-0528.2002.00021h.x","journal-title":"Immunol Rev"},{"issue":"2","key":"164_CR6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/hep.1840170208","volume":"17","author":"S Terasaki","year":"1993","unstructured":"Terasaki S et al (1993) Eosinophilic infiltration of the liver in primary biliary cirrhosis: a morphological study. Hepatology 17(2):206\u2013212. doi: 10.1002\/hep.1840170208","journal-title":"Hepatology"},{"issue":"2","key":"164_CR7","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/hep.22042","volume":"47","author":"ME Gershwin","year":"2008","unstructured":"Gershwin ME, Mackay IR (2008) The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology 47(2):737\u2013745. doi: 10.1002\/hep.22042","journal-title":"Hepatology"},{"issue":"3","key":"164_CR8","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1572-0241.2000.01857.x","volume":"95","author":"PM Huet","year":"2000","unstructured":"Huet PM et al (2000) Impact of fatigue on the quality of life of patients with primary biliary cirrhosis. Am J Gastroenterol 95(3):760\u2013767. doi: 10.1111\/j.1572-0241.2000.01857.x","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"164_CR9","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.jhep.2005.09.004","volume":"43","author":"NV Bergasa","year":"2005","unstructured":"Bergasa NV (2005) The pruritus of cholestasis. J Hepatol 43(6):1078\u20131088","journal-title":"J Hepatol"},{"issue":"3","key":"164_CR10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1055\/s-2005-916323","volume":"25","author":"YM Lee","year":"2005","unstructured":"Lee YM, Kaplan MM (2005) The natural history of PBC: has it changed? Semin Liver Dis 25(3):321\u2013326. doi: 10.1055\/s-2005-916323","journal-title":"Semin Liver Dis"},{"issue":"2","key":"164_CR11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/j.gastro.2004.11.009","volume":"128","author":"C Corpechot","year":"2005","unstructured":"Corpechot C et al (2005) The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. Gastroenterology 128(2):297\u2013303. doi: 10.1053\/j.gastro.2004.11.009","journal-title":"Gastroenterology"},{"issue":"3","key":"164_CR12","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","volume":"130","author":"A Pares","year":"2006","unstructured":"Pares A, Caballeria L, Rodes J (2006) Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid. Gastroenterology 130(3):715\u2013720. doi: 10.1053\/j.gastro.2005.12.029","journal-title":"Gastroenterology"},{"issue":"3","key":"164_CR13","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22428","volume":"48","author":"C Corpechot","year":"2008","unstructured":"Corpechot C et al (2008) Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatology 48(3):871\u2013877. doi: 10.1002\/hep.22428","journal-title":"Hepatology"},{"issue":"4","key":"164_CR14","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1053\/j.gastro.2009.01.003","volume":"136","author":"EM Kuiper","year":"2009","unstructured":"Kuiper EM et al (2009) Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid. Gastroenterology 136(4):1281\u20131287. doi: 10.1053\/j.gastro.2009.01.003","journal-title":"Gastroenterology"},{"issue":"9","key":"164_CR15","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1056\/NEJM198702263160907","volume":"316","author":"MM Kaplan","year":"1987","unstructured":"Kaplan MM (1987) Primary biliary cirrhosis. N Engl J Med 316(9):521\u2013528","journal-title":"N Engl J Med"},{"issue":"6","key":"164_CR16","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/gut.15.6.473","volume":"15","author":"AN Hamlyn","year":"1974","unstructured":"Hamlyn AN, Sherlock S (1974) The epidemiology of primary biliary cirrhosis: a survey of mortality in England and Wales. Gut 15(6):473\u2013479. doi: 10.1136\/gut.15.6.473","journal-title":"Gut"},{"issue":"3","key":"164_CR17","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/hep.1840110317","volume":"11","author":"A Danielsson","year":"1990","unstructured":"Danielsson A, Boqvist L, Uddenfeldt P (1990) Epidemiology of primary biliary cirrhosis in a defined rural population in the northern part of Sweden. Hepatology 11(3):458\u2013464. doi: 10.1002\/hep.1840110317","journal-title":"Hepatology"},{"issue":"1","key":"164_CR18","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/hep.1840120116","volume":"12","author":"H Witt-Sullivan","year":"1990","unstructured":"Witt-Sullivan H et al (1990) The demography of primary biliary cirrhosis in Ontario, Canada. Hepatology 12(1):98\u2013105. doi: 10.1002\/hep.1840120116","journal-title":"Hepatology"},{"issue":"6","key":"164_CR19","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1053\/gast.2000.20197","volume":"119","author":"WR Kim","year":"2000","unstructured":"Kim WR et al (2000) Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology 119(6):1631\u20131636. doi: 10.1053\/gast.2000.20197","journal-title":"Gastroenterology"},{"issue":"6","key":"164_CR20","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/gut.36.6.927","volume":"36","author":"RG Watson","year":"1995","unstructured":"Watson RG et al (1995) Low prevalence of primary biliary cirrhosis in Victoria, Australia. Melbourne Liver Group. Gut 36(6):927\u2013930. doi: 10.1136\/gut.36.6.927","journal-title":"Gut"},{"issue":"2","key":"164_CR21","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/hep.510300213","volume":"30","author":"OF James","year":"1999","unstructured":"James OF et al (1999) Primary biliary cirrhosis once rare, now common in the United Kingdom? Hepatology 30(2):390\u2013394. doi: 10.1002\/hep.510300213","journal-title":"Hepatology"},{"issue":"9","key":"164_CR22","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1111\/j.1572-0241.2002.06019.x","volume":"97","author":"KJ Hurlburt","year":"2002","unstructured":"Hurlburt KJ et al (2002) Prevalence of autoimmune liver disease in Alaska Natives. Am J Gastroenterol 97(9):2402\u20132407. doi: 10.1111\/j.1572-0241.2002.06019.x","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"164_CR23","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/01.mcg.0000225653.07932.8f","volume":"41","author":"KN Lazaridis","year":"2007","unstructured":"Lazaridis KN, Talwalkar JA (2007) Clinical epidemiology of primary biliary cirrhosis: incidence, prevalence, and impact of therapy. J Clin Gastroenterol 41(5):494\u2013500. doi: 10.1097\/01.mcg.0000225653.07932.8f","journal-title":"J Clin Gastroenterol"},{"issue":"10","key":"164_CR24","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/BF02374468","volume":"36","author":"M Karvonen","year":"1993","unstructured":"Karvonen M et al (1993) A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus. World Health Organization DIAMOND Project Group. Diabetologia 36(10):883\u2013892. doi: 10.1007\/BF02374468","journal-title":"Diabetologia"},{"issue":"894","key":"164_CR25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/pmj.76.894.199","volume":"76","author":"MI Prince","year":"2000","unstructured":"Prince MI, Jones DE (2000) Primary biliary cirrhosis: new perspectives in diagnosis and treatment. Postgrad Med J 76(894):199\u2013206. doi: 10.1136\/pmj.76.894.199","journal-title":"Postgrad Med J"},{"issue":"4","key":"164_CR26","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1386-6346(01)00148-6","volume":"22","author":"T Nakano","year":"2002","unstructured":"Nakano T et al (2002) Long-term prognosis of primary biliary cirrhosis (PBC) in Japan and analysis of the factors of stage progression in asymptomatic PBC (a-PBC). Hepatol Res 22(4):250\u2013260. doi: 10.1016\/S1386-6346(01)00148-6","journal-title":"Hepatol Res"},{"issue":"4","key":"164_CR27","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1053\/gast.2002.36027","volume":"123","author":"M Prince","year":"2002","unstructured":"Prince M et al (2002) Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28\u00a0years. Gastroenterology 123(4):1044\u20131051. doi: 10.1053\/gast.2002.36027","journal-title":"Gastroenterology"},{"issue":"4","key":"164_CR28","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1053\/he.2000.5984","volume":"31","author":"EJ Heathcote","year":"2000","unstructured":"Heathcote EJ (2000) Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology 31(4):1005\u20131013. doi: 10.1053\/he.2000.5984","journal-title":"Hepatology"},{"key":"164_CR29","unstructured":"EASL (2009) Clinical practice guidelines: management of cholestatic liver diseases. J Hepatol. doi: 10.1016\/j.jhep2009.04.009"},{"issue":"3","key":"164_CR30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.0954-6820.1986.tb02758.x","volume":"220","author":"R Jorde","year":"1986","unstructured":"Jorde R, Rekvig OP, Bostad L (1986) A follow-up study of 68 patients with anti-mitochondrial antibodies (AMA). Acta Med Scand 220(3):241\u2013247","journal-title":"Acta Med Scand"},{"issue":"2","key":"164_CR31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/gut.20.2.137","volume":"20","author":"JM Shapiro","year":"1979","unstructured":"Shapiro JM, Smith H, Schaffner F (1979) Serum bilirubin: a prognostic factor in primary biliary cirrhosis. Gut 20(2):137\u2013140. doi: 10.1136\/gut.20.2.137","journal-title":"Gut"},{"issue":"2","key":"164_CR32","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.atherosclerosis.2006.11.036","volume":"194","author":"A Sorokin","year":"2007","unstructured":"Sorokin A, Brown JL, Thompson PD (2007) Primary biliary cirrhosis, hyperlipidemia, and atherosclerotic risk: a systematic review. Atherosclerosis 194(2):293\u2013299. doi: 10.1016\/j.atherosclerosis.2006.11.036","journal-title":"Atherosclerosis"},{"issue":"9","key":"164_CR33","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1172\/JCI3597","volume":"102","author":"RP Elferink","year":"1998","unstructured":"Elferink RP et al (1998) Class III P-glycoproteins mediate the formation of lipoprotein X in the mouse. J Clin Invest 102(9):1749\u20131757. doi: 10.1172\/JCI3597","journal-title":"J Clin Invest"},{"issue":"15","key":"164_CR34","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMc071467","volume":"357","author":"TC Su","year":"2007","unstructured":"Su TC, Hwang JJ, Kao JH (2007) Hypercholesterolemia in primary biliary cirrhosis. N Engl J Med 357(15):1561\u20131562. doi: 10.1056\/NEJMc071467","journal-title":"N Engl J Med"},{"issue":"4","key":"164_CR35","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/hep.1840170408","volume":"17","author":"RE Poupon","year":"1993","unstructured":"Poupon RE et al (1993) Cholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis. Hepatology 17(4):577\u2013582. doi: 10.1002\/hep.1840170408","journal-title":"Hepatology"},{"issue":"6","key":"164_CR36","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/hep.1840060609","volume":"6","author":"HC Mitchison","year":"1986","unstructured":"Mitchison HC et al (1986) Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis? Hepatology 6(6):1279\u20131284. doi: 10.1002\/hep.1840060609","journal-title":"Hepatology"},{"issue":"9039","key":"164_CR37","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(96)04410-8","volume":"348","author":"JV Metcalf","year":"1996","unstructured":"Metcalf JV et al (1996) Natural history of early primary biliary cirrhosis. Lancet 348(9039):1399\u20131402. doi: 10.1016\/S0140-6736(96)04410-8","journal-title":"Lancet"},{"issue":"38","key":"164_CR38","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1055\/s-2008-1068269","volume":"112","author":"G Brunner","year":"1987","unstructured":"Brunner G, Klinge O (1987) A chronic destructive non-suppurative cholangitis-like disease picture with antinuclear antibodies (immunocholangitis). Dtsch Med Wochenschr 112(38):1454\u20131458. doi: 10.1055\/s-2008-1068269","journal-title":"Dtsch Med Wochenschr"},{"issue":"1","key":"164_CR39","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/hep.1840180103","volume":"18","author":"Z Ben-Ari","year":"1993","unstructured":"Ben-Ari Z, Dhillon AP, Sherlock S (1993) Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis. Hepatology 18(1):10\u201315. doi: 10.1002\/hep.1840180103","journal-title":"Hepatology"},{"issue":"2","key":"164_CR40","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/gut.35.2.260","volume":"35","author":"P Michieletti","year":"1994","unstructured":"Michieletti P et al (1994) Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis. Gut 35(2):260\u2013265. doi: 10.1136\/gut.35.2.260","journal-title":"Gut"},{"issue":"1","key":"164_CR41","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00000478-199401000-00009","volume":"18","author":"SL Taylor","year":"1994","unstructured":"Taylor SL, Dean PJ, Riely CA (1994) Primary autoimmune cholangitis. An alternative to antimitochondrial antibody-negative primary biliary cirrhosis. Am J Surg Pathol 18(1):91\u201399. doi: 10.1097\/00000478-199401000-00009","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"164_CR42","first-page":"247","volume":"90","author":"MA Lacerda","year":"1995","unstructured":"Lacerda MA et al (1995) Antimitochondrial antibody-negative primary biliary cirrhosis. Am J Gastroenterol 90(2):247\u2013249","journal-title":"Am J Gastroenterol"},{"issue":"9377","key":"164_CR43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(03)13808-1","volume":"362","author":"JA Talwalkar","year":"2003","unstructured":"Talwalkar JA, Lindor KD (2003) Primary biliary cirrhosis. Lancet 362(9377):53\u201361. doi: 10.1016\/S0140-6736(03)13808-1","journal-title":"Lancet"},{"issue":"2","key":"164_CR44","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaut.2008.05.003","volume":"31","author":"S Shimoda","year":"2008","unstructured":"Shimoda S et al (2008) CD4 T-cell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosis. J Autoimmun 31(2):110\u2013115. doi: 10.1016\/j.jaut.2008.05.003","journal-title":"J Autoimmun"},{"issue":"4","key":"164_CR45","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1053\/gast.2003.50144","volume":"124","author":"JF Lucena","year":"2003","unstructured":"Lucena JF et al (2003) A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis. Gastroenterology 124(4):1037\u20131042. doi: 10.1053\/gast.2003.50144","journal-title":"Gastroenterology"},{"issue":"13","key":"164_CR46","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1056\/NEJM197309272891306","volume":"289","author":"S Sherlock","year":"1973","unstructured":"Sherlock S, Scheuer PJ (1973) The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med 289(13):674\u2013678","journal-title":"N Engl J Med"},{"issue":"2","key":"164_CR47","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1053\/j.gastro.2004.11.005","volume":"128","author":"K Kikuchi","year":"2005","unstructured":"Kikuchi K et al (2005) Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis. Gastroenterology 128(2):304\u2013312. doi: 10.1053\/j.gastro.2004.11.005","journal-title":"Gastroenterology"},{"issue":"1","key":"164_CR48","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0168-8278(87)80055-7","volume":"5","author":"D Zauli","year":"1987","unstructured":"Zauli D et al (1987) An autoantibody profile in primary sclerosing cholangitis. J Hepatol 5(1):14\u201318. doi: 10.1016\/S0168-8278(87)80055-7","journal-title":"J Hepatol"},{"issue":"2","key":"164_CR49","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1148\/radiology.220.2.r01au36329","volume":"220","author":"A Blachar","year":"2001","unstructured":"Blachar A, Federle MP, Brancatelli G (2001) Primary biliary cirrhosis: clinical, pathologic, and helical CT findings in 53 patients. Radiology 220(2):329\u2013336","journal-title":"Radiology"},{"issue":"12","key":"164_CR50","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1155\/2007\/621489","volume":"21","author":"L Abenavoli","year":"2007","unstructured":"Abenavoli L, Corpechot C, Poupon R (2007) Elastography in hepatology. Can J Gastroenterol 21(12):839\u2013842","journal-title":"Can J Gastroenterol"},{"issue":"5","key":"164_CR51","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/hep.21151","volume":"43","author":"C Corpechot","year":"2006","unstructured":"Corpechot C et al (2006) Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology 43(5):1118\u20131124. doi: 10.1002\/hep.21151","journal-title":"Hepatology"},{"issue":"2","key":"164_CR52","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00432479","volume":"379","author":"J Ludwig","year":"1978","unstructured":"Ludwig J, Dickson ER, McDonald GS (1978) Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol 379(2):103\u2013112. doi: 10.1007\/BF00432479","journal-title":"Virchows Arch A Pathol Anat Histol"},{"issue":"Suppl 4","key":"164_CR53","first-page":"106","volume":"59","author":"PJ Scheuer","year":"1983","unstructured":"Scheuer PJ (1983) Primary biliary cirrhosis: diagnosis, pathology and pathogenesis. Postgrad Med J 59(Suppl 4):106\u2013115. doi: 10.1136\/pgmj.59.688.106","journal-title":"Postgrad Med J"},{"issue":"1","key":"164_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198301063080101","volume":"308","author":"J Roll","year":"1983","unstructured":"Roll J et al (1983) The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis. N Engl J Med 308(1):1\u20137","journal-title":"N Engl J Med"},{"issue":"4","key":"164_CR55","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1089-3261(03)00100-4","volume":"7","author":"A Pares","year":"2003","unstructured":"Pares A, Rodes J (2003) Natural history of primary biliary cirrhosis. Clin Liver Dis 7(4):779\u2013794. doi: 10.1016\/S1089-3261(03)00100-4","journal-title":"Clin Liver Dis"},{"issue":"6","key":"164_CR56","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/gut.2003.023937","volume":"53","author":"MI Prince","year":"2004","unstructured":"Prince MI et al (2004) Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort. Gut 53(6):865\u2013870. doi: 10.1136\/gut.2003.023937","journal-title":"Gut"},{"issue":"4","key":"164_CR57","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/gut.2003.025155","volume":"53","author":"P Milkiewicz","year":"2004","unstructured":"Milkiewicz P, Heathcote EJ (2004) Fatigue in chronic cholestasis. Gut 53(4):475\u2013477. doi: 10.1136\/gut.2003.025155","journal-title":"Gut"},{"issue":"10","key":"164_CR58","first-page":"1840","volume":"89","author":"JM Laurin","year":"1994","unstructured":"Laurin JM et al (1994) The natural history of abdominal pain associated with primary biliary cirrhosis. Am J Gastroenterol 89(10):1840\u20131843","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"164_CR59","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/gut.43.5.705","volume":"43","author":"K Cauch-Dudek","year":"1998","unstructured":"Cauch-Dudek K et al (1998) Fatigue in primary biliary cirrhosis. Gut 43(5):705\u2013710","journal-title":"Gut"},{"key":"164_CR60","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cgh.2007.11.021","volume":"6","author":"JL Newton","year":"2008","unstructured":"Newton JL et al (2008) A predictive model for fatigue and its aetiologica associations in primary biliary cirrhosis. Clin Gastroenterol Hepatol 6:228\u2013233. doi: 10.1016\/j.cgh.2007.11.021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"164_CR61","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jhep.2007.03.006","volume":"46","author":"DEJ Jones","year":"2007","unstructured":"Jones DEJ (2007) Fatigue in cholestatic liver disease: is it all in the mind? J Hepatol 46:992\u2013994. doi: 10.1016\/j.jhep.2007.03.006","journal-title":"J Hepatol"},{"issue":"4","key":"164_CR62","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1542-3565(03)00134-4","volume":"1","author":"JA Talwalkar","year":"2003","unstructured":"Talwalkar JA et al (2003) Natural history of pruritus in primary biliary cirrhosis. Clin Gastroenterol Hepatol 1(4):297\u2013302. doi: 10.1016\/S1542-3565(03)00134-4","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"15","key":"164_CR63","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.2165\/00003495-200868150-00006","volume":"68","author":"AE Kremer","year":"2008","unstructured":"Kremer AE et al (2008) Pathogenesis and treatment of pruritus in cholestasis. Drugs 68(15):2163\u20132182. doi: 10.2165\/00003495-200868150-00006","journal-title":"Drugs"},{"issue":"4 Pt 1","key":"164_CR64","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0016-5085(92)90771-P","volume":"102","author":"F Colina","year":"1992","unstructured":"Colina F et al (1992) Nodular regenerative hyperplasia of the liver in early histological stages of primary biliary cirrhosis. Gastroenterology 102(4 Pt 1):1319\u20131324","journal-title":"Gastroenterology"},{"issue":"5","key":"164_CR65","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1053\/j.gastro.2008.07.019","volume":"135","author":"PM Huet","year":"2008","unstructured":"Huet PM et al (2008) Portal hypertension and primary biliary cirrhosis: effect of long-term ursodeoxycholic acid treatment. Gastroenterology 135(5):1552\u20131560. doi: 10.1053\/j.gastro.2008.07.019","journal-title":"Gastroenterology"},{"issue":"5","key":"164_CR66","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1053\/j.gastro.2008.09.041","volume":"135","author":"MJ Mayo","year":"2008","unstructured":"Mayo MJ (2008) Portal hypertension in primary biliary cirrhosis: a potentially reversible harbinger of demise. Gastroenterology 135(5):1450\u20131451. doi: 10.1053\/j.gastro.2008.09.041","journal-title":"Gastroenterology"},{"issue":"1","key":"164_CR67","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0016-5085(00)70423-9","volume":"118","author":"JE Springer","year":"2000","unstructured":"Springer JE et al (2000) Vitamin D-receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis. Gastroenterology 118(1):145\u2013151. doi: 10.1016\/S0016-5085(00)70423-9","journal-title":"Gastroenterology"},{"issue":"6 (Pt 1)","key":"164_CR68","doi-asserted-by":"crossref","first-page":"855","DOI":"10.7326\/0003-4819-103-6-855","volume":"103","author":"SF Hodgson","year":"1985","unstructured":"Hodgson SF et al (1985) Bone loss and reduced osteoblast function in primary biliary cirrhosis. Ann Intern Med 103(6 (Pt 1)):855\u2013860","journal-title":"Ann Intern Med"},{"issue":"6","key":"164_CR69","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0016-5085(82)80125-X","volume":"83","author":"O Epstein","year":"1982","unstructured":"Epstein O et al (1982) The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis. Gastroenterology 83(6):1177\u20131182","journal-title":"Gastroenterology"},{"issue":"5","key":"164_CR70","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/hep.1840050522","volume":"5","author":"SJ Lanspa","year":"1985","unstructured":"Lanspa SJ et al (1985) Pathogenesis of steatorrhea in primary biliary cirrhosis. Hepatology 5(5):837\u2013842. doi: 10.1002\/hep.1840050522","journal-title":"Hepatology"},{"issue":"1","key":"164_CR71","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/gut.42.1.120","volume":"42","author":"JG Kingham","year":"1998","unstructured":"Kingham JG, Parker DR (1998) The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences. Gut 42(1):120\u2013122","journal-title":"Gut"},{"issue":"4","key":"164_CR72","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/hep.1840090403","volume":"9","author":"SJ Munoz","year":"1989","unstructured":"Munoz SJ et al (1989) Vitamin E deficiency in primary biliary cirrhosis: gastrointestinal malabsorption, frequency and relationship to other lipid-soluble vitamins. Hepatology 9(4):525\u2013531. doi: 10.1002\/hep.1840090403","journal-title":"Hepatology"},{"issue":"2","key":"164_CR73","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/gut.25.2.133","volume":"25","author":"AK Burroughs","year":"1984","unstructured":"Burroughs AK et al (1984) Bacteriuria and primary biliary cirrhosis. Gut 25(2):133\u2013137. doi: 10.1136\/gut.25.2.133","journal-title":"Gut"},{"issue":"6","key":"164_CR74","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0002-9343(84)90861-1","volume":"76","author":"AM Wolke","year":"1984","unstructured":"Wolke AM et al (1984) Malignancy in primary biliary cirrhosis. Incidence of breast cancer in affected women. High Am J Med 76(6):1075\u20131078. doi: 10.1016\/0002-9343(84)90861-1","journal-title":"High Am J Med"},{"issue":"6509","key":"164_CR75","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1136\/bmj.291.6509.1597","volume":"291","author":"BM Goudie","year":"1985","unstructured":"Goudie BM et al (1985) Breast cancer in women with primary biliary cirrhosis. Br Med J (Clin Res Ed) 291(6509):1597\u20131598. doi: 10.1136\/bmj.291.6509.1597","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"1 Pt 1","key":"164_CR76","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/hep.1840200116","volume":"20","author":"L Loof","year":"1994","unstructured":"Loof L et al (1994) Cancer risk in primary biliary cirrhosis: a population-based study from Sweden. Hepatology 20(1 Pt 1):101\u2013104","journal-title":"Hepatology"},{"issue":"5","key":"164_CR77","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/hep.510260508","volume":"26","author":"DE Jones","year":"1997","unstructured":"Jones DE et al (1997) Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes. Hepatology 26(5):1138\u20131142. doi: 10.1002\/hep.510260508","journal-title":"Hepatology"},{"issue":"5","key":"164_CR78","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/hep.510290511","volume":"29","author":"PK Nijhawan","year":"1999","unstructured":"Nijhawan PK et al (1999) Incidence of cancer in primary biliary cirrhosis: the Mayo experience. Hepatology 29(5):1396\u20131398. doi: 10.1002\/hep.510290511","journal-title":"Hepatology"},{"issue":"5","key":"164_CR79","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1053\/jhep.2002.33157","volume":"35","author":"A Shibuya","year":"2002","unstructured":"Shibuya A et al (2002) Hepatocellular carcinoma and survival in patients with primary biliary cirrhosis. Hepatology 35(5):1172\u20131178. doi: 10.1053\/jhep.2002.33157","journal-title":"Hepatology"},{"issue":"6","key":"164_CR80","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0016-5085(19)30497-4","volume":"78","author":"JP Crowe","year":"1980","unstructured":"Crowe JP et al (1980) Primary biliary cirrhosis: the prevalence of hypothyroidism and its relationship to thyroid autoantibodies and sicca syndrome. Gastroenterology 78(6):1437\u20131441","journal-title":"Gastroenterology"},{"issue":"3","key":"164_CR81","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/PL00009532","volume":"12","author":"FW Mang","year":"1997","unstructured":"Mang FW et al (1997) Primary biliary cirrhosis, sicca complex, and dysphagia. Dysphagia 12(3):167\u2013170. doi: 10.1007\/PL00009532","journal-title":"Dysphagia"},{"issue":"3","key":"164_CR82","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/0002-9343(71)90218-X","volume":"50","author":"TB Reynolds","year":"1971","unstructured":"Reynolds TB et al (1971) Primary biliary cirrhosis with scleroderma. Raynaud's phenomenon and telangiectasia. New syndrome. Am J Med 50(3):302\u2013312. doi: 10.1016\/0002-9343(71)90218-X","journal-title":"Am J Med"},{"issue":"6","key":"164_CR83","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/0016-5085(87)90636-6","volume":"92","author":"A Bush","year":"1987","unstructured":"Bush A et al (1987) Primary biliary cirrhosis and ulcerative colitis. Gastroenterology 92(6):2009\u20132013","journal-title":"Gastroenterology"},{"issue":"11","key":"164_CR84","first-page":"1615","volume":"56","author":"DE Jones","year":"2007","unstructured":"Jones DE (2007) Pathogenesis of primary biliary cirrhosis. Gut 56(11):1615\u20131624","journal-title":"Gut"},{"issue":"1","key":"164_CR85","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/jaut.1999.0299","volume":"13","author":"K Tsuji","year":"1999","unstructured":"Tsuji K et al (1999) Familial primary biliary cirrhosis in Hiroshima. J Autoimmun 13(1):171\u2013178. doi: 10.1006\/jaut.1999.0299","journal-title":"J Autoimmun"},{"issue":"2\u20133","key":"164_CR86","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaut.2007.02.003","volume":"28","author":"R Rieger","year":"2007","unstructured":"Rieger R, Gershwin ME (2007) The X and why of xenobiotics in primary biliary cirrhosis. J Autoimmun 28(2\u20133):76\u201384. doi: 10.1016\/j.jaut.2007.02.003","journal-title":"J Autoimmun"},{"issue":"4","key":"164_CR87","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1053\/j.gastro.2008.08.020","volume":"135","author":"P Invernizzi","year":"2008","unstructured":"Invernizzi P, Gershwin ME (2008) The genetic basis of primary biliary cirrhosis: premises, not promises. Gastroenterology 135(4):1044\u20131047. doi: 10.1053\/j.gastro.2008.08.020","journal-title":"Gastroenterology"},{"issue":"5","key":"164_CR88","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1542-3565(04)00678-0","volume":"3","author":"P Invernizzi","year":"2005","unstructured":"Invernizzi P et al (2005) From bases to basis: linking genetics to causation in primary biliary cirrhosis. Clin Gastroenterol Hepatol 3(5):401\u2013410. doi: 10.1016\/S1542-3565(04)00678-0","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"164_CR89","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1053\/j.gastro.2004.05.005","volume":"127","author":"C Selmi","year":"2004","unstructured":"Selmi C et al (2004) Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 127(2):485\u2013492. doi: 10.1053\/j.gastro.2004.05.005","journal-title":"Gastroenterology"},{"issue":"3","key":"164_CR90","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0168-8278(99)80097-X","volume":"30","author":"DE Jones","year":"1999","unstructured":"Jones DE et al (1999) Familial primary biliary cirrhosis reassessed: a geographically-based population study. J Hepatol 30(3):402\u2013407. doi: 10.1016\/S0168-8278(99)80097-X","journal-title":"J Hepatol"},{"issue":"2","key":"164_CR91","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1006\/clim.1999.4690","volume":"91","author":"A Parikh-Patel","year":"1999","unstructured":"Parikh-Patel A et al (1999) The geoepidemiology of primary biliary cirrhosis: contrasts and comparisons with the spectrum of autoimmune diseases. Clin Immunol 91(2):206\u2013218. doi: 10.1006\/clim.1999.4690","journal-title":"Clin Immunol"},{"issue":"1","key":"164_CR92","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1055\/s-2007-1007179","volume":"17","author":"J Metcalf","year":"1997","unstructured":"Metcalf J, James O (1997) The geoepidemiology of primary biliary cirrhosis. Semin Liver Dis 17(1):13\u201322. doi: 10.1055\/s-2007-1007179","journal-title":"Semin Liver Dis"},{"issue":"6","key":"164_CR93","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/hep.1840160616","volume":"16","author":"J Underhill","year":"1992","unstructured":"Underhill J et al (1992) Susceptibility to primary biliary cirrhosis is associated with the HLA-DR8-DQB1*0402 haplotype. Hepatology 16(6):1404\u20131408. doi: 10.1002\/hep.1840160616","journal-title":"Hepatology"},{"issue":"3","key":"164_CR94","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/hep.21316","volume":"44","author":"PT Donaldson","year":"2006","unstructured":"Donaldson PT et al (2006) HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: a large-scale study. Hepatology 44(3):667\u2013674. doi: 10.1002\/hep.21316","journal-title":"Hepatology"},{"issue":"2","key":"164_CR95","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1399-0039.2005.00351.x","volume":"65","author":"ME Mullarkey","year":"2005","unstructured":"Mullarkey ME et al (2005) Human leukocyte antigen class II alleles in Caucasian women with primary biliary cirrhosis. Tissue Antigens 65(2):199\u2013205. doi: 10.1111\/j.1399-0039.2005.00351.x","journal-title":"Tissue Antigens"},{"issue":"5","key":"164_CR96","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1034\/j.1399-0039.2002.590504.x","volume":"59","author":"R Wassmuth","year":"2002","unstructured":"Wassmuth R et al (2002) HLA class II markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosis. Tissue Antigens 59(5):381\u2013387. doi: 10.1034\/j.1399-0039.2002.590504.x","journal-title":"Tissue Antigens"},{"issue":"1","key":"164_CR97","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0168-8278(01)00237-9","volume":"36","author":"J Stone","year":"2002","unstructured":"Stone J et al (2002) Human leukocyte antigen class II associations in serum antimitochondrial antibodies (AMA)-positive and AMA-negative primary biliary cirrhosis. J Hepatol 36(1):8\u201313. doi: 10.1016\/S0168-8278(01)00237-9","journal-title":"J Hepatol"},{"issue":"6","key":"164_CR98","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0168-8278(05)80617-8","volume":"21","author":"S Onishi","year":"1994","unstructured":"Onishi S et al (1994) DNA typing of HLA class II genes; DRB1*0803 increases the susceptibility of Japanese to primary biliary cirrhosis. J Hepatol 21(6):1053\u20131060. doi: 10.1016\/S0168-8278(05)80617-8","journal-title":"J Hepatol"},{"issue":"6","key":"164_CR99","first-page":"410","volume":"13","author":"HY Liu","year":"2005","unstructured":"Liu HY et al (2005) Analysis of HLA alleles polymorphism in Chinese patients with primary biliary cirrhosis. Zhonghua Gan Zang Bing Za Zhi 13(6):410\u2013413","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"5","key":"164_CR100","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/hep.1840070516","volume":"7","author":"GJ Gores","year":"1987","unstructured":"Gores GJ et al (1987) Primary biliary cirrhosis: associations with class II major histocompatibility complex antigens. Hepatology 7(5):889\u2013892. doi: 10.1002\/hep.1840070516","journal-title":"Hepatology"},{"issue":"4","key":"164_CR101","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0168-8278(02)00440-3","volume":"38","author":"P Invernizzi","year":"2003","unstructured":"Invernizzi P et al (2003) Peculiar HLA polymorphisms in Italian patients with primary biliary cirrhosis. J Hepatol 38(4):401\u2013406. doi: 10.1016\/S0168-8278(02)00440-3","journal-title":"J Hepatol"},{"issue":"1","key":"164_CR102","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.1840180113","volume":"18","author":"T Seki","year":"1993","unstructured":"Seki T et al (1993) Association of primary biliary cirrhosis with human leukocyte antigen DPB1*0501 in Japanese patients. Hepatology 18(1):73\u201378. doi: 10.1002\/hep.1840180113","journal-title":"Hepatology"},{"issue":"6","key":"164_CR103","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/hep.22567","volume":"48","author":"P Invernizzi","year":"2008","unstructured":"Invernizzi P et al (2008) Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology 48(6):1906\u20131912. doi: 10.1002\/hep.22567","journal-title":"Hepatology"},{"issue":"4","key":"164_CR104","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0168-8278(00)80213-5","volume":"32","author":"K Agarwal","year":"2000","unstructured":"Agarwal K et al (2000) CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. J Hepatol 32(4):538\u2013541. doi: 10.1016\/S0168-8278(00)80213-5","journal-title":"J Hepatol"},{"issue":"6939","key":"164_CR105","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature01621","volume":"423","author":"H Ueda","year":"2003","unstructured":"Ueda H et al (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423(6939):506\u2013511. doi: 10.1038\/nature01621","journal-title":"Nature"},{"issue":"1","key":"164_CR106","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1677\/jme.0.0310021","volume":"31","author":"DA Chistiakov","year":"2003","unstructured":"Chistiakov DA, Turakulov RI (2003) CTLA-4 and its role in autoimmune thyroid disease. J Mol Endocrinol 31(1):21\u201336. doi: 10.1677\/jme.0.0310021","journal-title":"J Mol Endocrinol"},{"issue":"4","key":"164_CR107","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.smim.2006.03.011","volume":"18","author":"S Krishnan","year":"2006","unstructured":"Krishnan S, Chowdhury B, Tsokos GC (2006) Autoimmunity in systemic lupus erythematosus: integrating genes and biology. Semin Immunol 18(4):230\u2013243. doi: 10.1016\/j.smim.2006.03.011","journal-title":"Semin Immunol"},{"issue":"4","key":"164_CR108","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1089-3261(03)00095-3","volume":"7","author":"DE Jones","year":"2003","unstructured":"Jones DE, Donaldson PT (2003) Genetic factors in the pathogenesis of primary biliary cirrhosis. Clin Liver Dis 7(4):841\u2013864. doi: 10.1016\/S1089-3261(03)00095-3","journal-title":"Clin Liver Dis"},{"issue":"7","key":"164_CR109","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/sj.gene.6364248","volume":"6","author":"C Selmi","year":"2005","unstructured":"Selmi C et al (2005) Genes and (auto) immunity in primary biliary cirrhosis. Genes Immun 6(7):543\u2013556. doi: 10.1038\/sj.gene.6364248","journal-title":"Genes Immun"},{"issue":"11","key":"164_CR110","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/MEG.0b013e3282efa240","volume":"19","author":"E Schott","year":"2007","unstructured":"Schott E et al (2007) Association of CTLA4 single nucleotide polymorphisms with viral but not autoimmune liver disease. Eur J Gastroenterol Hepatol 19(11):947\u2013951. doi: 10.1097\/MEG.0b013e3282efa240","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"164_CR111","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/hep.22048","volume":"47","author":"BD Juran","year":"2008","unstructured":"Juran BD et al (2008) Interacting alleles of the coinhibitory immunoreceptor genes cytotoxic T-lymphocyte antigen 4 and programmed cell-death 1 influence risk and features of primary biliary cirrhosis. Hepatology 47(2):563\u2013570. doi: 10.1002\/hep.22048","journal-title":"Hepatology"},{"issue":"6","key":"164_CR112","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jhep.2008.07.027","volume":"49","author":"R Poupon","year":"2008","unstructured":"Poupon R et al (2008) Genetic factors of susceptibility and of severity in primary biliary cirrhosis. J Hepatol 49(6):1038\u20131045. doi: 10.1016\/j.jhep.2008.07.027","journal-title":"J Hepatol"},{"issue":"2","key":"164_CR113","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1142\/S021972000300006X","volume":"1","author":"M Takahashi","year":"2003","unstructured":"Takahashi M et al (2003) Automated identification of single nucleotide polymorphisms from sequencing data. J Bioinform Comput Biol 1(2):253\u2013265. doi: 10.1142\/S021972000300006X","journal-title":"J Bioinform Comput Biol"},{"issue":"3","key":"164_CR114","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/hep.20159","volume":"39","author":"C Pauli-Magnus","year":"2004","unstructured":"Pauli-Magnus C et al (2004) BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 39(3):779\u2013791. doi: 10.1002\/hep.20159","journal-title":"Hepatology"},{"key":"164_CR115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-008-8084-z","volume":"36","author":"U Beuers","year":"2009","unstructured":"Beuers U (2009) Crosstalk of liver, bile ducts and the gut. Clin Rev Allergy Immunol 36:1\u20133","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"164_CR116","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2006.06.002","volume":"27","author":"R Rieger","year":"2006","unstructured":"Rieger R et al (2006) Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis. J Autoimmun 27(1):7\u201316. doi: 10.1016\/j.jaut.2006.06.002","journal-title":"J Autoimmun"},{"issue":"5","key":"164_CR117","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.20907","volume":"42","author":"ME Gershwin","year":"2005","unstructured":"Gershwin ME et al (2005) Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology 42(5):1194\u20131202. doi: 10.1002\/hep.20907","journal-title":"Hepatology"},{"issue":"9408","key":"164_CR118","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(04)15541-4","volume":"363","author":"P Invernizzi","year":"2004","unstructured":"Invernizzi P et al (2004) Frequency of monosomy X in women with primary biliary cirrhosis. Lancet 363(9408):533\u2013535. doi: 10.1016\/S0140-6736(04)15541-4","journal-title":"Lancet"},{"issue":"10","key":"164_CR119","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1155\/2005\/180515","volume":"19","author":"P Milkiewicz","year":"2005","unstructured":"Milkiewicz P, Heathcote J (2005) Primary biliary cirrhosis in a patient with Turner syndrome. Can J Gastroenterol 19(10):631\u2013633","journal-title":"Can J Gastroenterol"},{"issue":"7","key":"164_CR120","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00042737-200207000-00004","volume":"14","author":"LP Lakatos","year":"2002","unstructured":"Lakatos LP et al (2002) Vitamin D receptor, oestrogen receptor-alpha gene and interleukin-1 receptor antagonist gene polymorphisms in Hungarian patients with primary biliary cirrhosis. Eur J Gastroenterol Hepatol 14(7):733\u2013740. doi: 10.1097\/00042737-200207000-00004","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"164_CR121","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jhep.2004.08.022","volume":"41","author":"D Alvaro","year":"2004","unstructured":"Alvaro D et al (2004) Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis. J Hepatol 41(6):905\u2013912. doi: 10.1016\/j.jhep.2004.08.022","journal-title":"J Hepatol"},{"issue":"4","key":"164_CR122","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/hep.20164","volume":"39","author":"P Invernizzi","year":"2004","unstructured":"Invernizzi P et al (2004) Tamoxifen in treatment of primary biliary cirrhosis. Hepatology 39(4):1175\u20131176. doi: 10.1002\/hep.20164","journal-title":"Hepatology"},{"issue":"3","key":"164_CR123","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1478-3231.2004.00920.x","volume":"24","author":"A Reddy","year":"2004","unstructured":"Reddy A et al (2004) Tamoxifen: a novel treatment for primary biliary cirrhosis? Liver Int 24(3):194\u2013197. doi: 10.1111\/j.1478-3231.2004.00920.x","journal-title":"Liver Int"},{"issue":"3-4","key":"164_CR124","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jaut.2009.02.022","volume":"32","author":"KA Padgett","year":"2009","unstructured":"Padgett KA et al (2009) Primary biliary cirrhosis is associated with altered hepatic microRNA expression. J Autoimmun 32(3-4):246\u2013253. doi: 10.1016\/j.jaut.2009.02.022","journal-title":"J Autoimmun"},{"issue":"6243","key":"164_CR125","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/bmj.281.6243.772","volume":"281","author":"DR Triger","year":"1980","unstructured":"Triger DR (1980) Primary biliary cirrhosis: an epidemiological study. BMJ 281(6243):772\u2013775. doi: 10.1136\/bmj.281.6243.772","journal-title":"BMJ"},{"issue":"30","key":"164_CR126","first-page":"3048","volume":"46","author":"R Uibo","year":"1999","unstructured":"Uibo R, Salupere V (1999) The epidemiology of primary biliary cirrhosis: immunological problems. Hepatogastroenterology 46(30):3048\u20133052","journal-title":"Hepatogastroenterology"},{"issue":"6","key":"164_CR127","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1053\/jhep.2001.29760","volume":"34","author":"MI Prince","year":"2001","unstructured":"Prince MI et al (2001) The geographical distribution of primary biliary cirrhosis in a well-defined cohort. Hepatology 34(6):1083\u20131088. doi: 10.1053\/jhep.2001.29760","journal-title":"Hepatology"},{"issue":"3","key":"164_CR128","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/hep.21076","volume":"43","author":"A Ala","year":"2006","unstructured":"Ala A et al (2006) Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites. Hepatology 43(3):525\u2013531. doi: 10.1002\/hep.21076","journal-title":"Hepatology"},{"issue":"6","key":"164_CR129","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/hep.21423","volume":"44","author":"CO Zein","year":"2006","unstructured":"Zein CO et al (2006) Smoking and increased severity of hepatic fibrosis in primary biliary cirrhosis: a cross validated retrospective assessment. Hepatology 44(6):1564\u20131571. doi: 10.1002\/hep.21423","journal-title":"Hepatology"},{"issue":"3","key":"164_CR130","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0167-5699(98)80012-1","volume":"19","author":"P Griem","year":"1998","unstructured":"Griem P et al (1998) Allergic and autoimmune reactions to xenobiotics: how do they arise? Immunol Today 19(3):133\u2013141. doi: 10.1016\/S0167-5699(97)01219-X","journal-title":"Immunol Today"},{"issue":"9","key":"164_CR131","doi-asserted-by":"crossref","first-page":"5874","DOI":"10.4049\/jimmunol.174.9.5874","volume":"174","author":"K Amano","year":"2005","unstructured":"Amano K et al (2005) Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J Immunol 174(9):5874\u20135883","journal-title":"J Immunol"},{"issue":"3","key":"164_CR132","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1053\/jhep.2001.22653","volume":"33","author":"K Harada","year":"2001","unstructured":"Harada K et al (2001) Molecular identification of bacterial 16S ribosomal RNA gene in liver tissue of primary biliary cirrhosis: is propionibacterium acnes involved in granuloma formation? Hepatology 33(3):530\u2013536. doi: 10.1053\/jhep.2001.22653","journal-title":"Hepatology"},{"issue":"4","key":"164_CR133","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hep.20859","volume":"42","author":"TK Mao","year":"2005","unstructured":"Mao TK et al (2005) Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis. Hepatology 42(4):802\u2013808. doi: 10.1002\/hep.20859","journal-title":"Hepatology"},{"issue":"3","key":"164_CR134","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1053\/jhep.2002.35067","volume":"36","author":"DE Jones","year":"2002","unstructured":"Jones DE et al (2002) Bacterial motif DNA as an adjuvant for the breakdown of immune self-tolerance to pyruvate dehydrogenase complex. Hepatology 36(3):679\u2013686. doi: 10.1053\/jhep.2002.35067","journal-title":"Hepatology"},{"issue":"8677","key":"164_CR135","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0140-6736(89)92034-5","volume":"2","author":"U Hopf","year":"1989","unstructured":"Hopf U et al (1989) Relation between Escherichia coli R(rough)-forms in gut, lipid A in liver, and primary biliary cirrhosis. Lancet 2(8677):1419\u20131422. doi: 10.1016\/S0140-6736(89)92034-5","journal-title":"Lancet"},{"issue":"5","key":"164_CR136","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1053\/jhep.2003.50446","volume":"38","author":"C Selmi","year":"2003","unstructured":"Selmi C et al (2003) Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology 38(5):1250\u20131257. doi: 10.1053\/jhep.2003.50446","journal-title":"Hepatology"},{"issue":"2\u20134","key":"164_CR137","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/10446670310001642429","volume":"10","author":"PS Leung","year":"2003","unstructured":"Leung PS et al (2003) Is there a relation between Chlamydia infection and primary biliary cirrhosis? Clin Dev Immunol 10(2\u20134):227\u2013233. doi: 10.1080\/10446670310001642429","journal-title":"Clin Dev Immunol"},{"issue":"3","key":"164_CR138","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jhep.2003.11.033","volume":"40","author":"AS Abdulkarim","year":"2004","unstructured":"Abdulkarim AS et al (2004) Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumoniae? J Hepatol 40(3):380\u2013384. doi: 10.1016\/j.jhep.2003.11.033","journal-title":"J Hepatol"},{"issue":"1","key":"164_CR139","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1023\/A:1013292210036","volume":"47","author":"K Dohmen","year":"2002","unstructured":"Dohmen K et al (2002) Atrophic corpus gastritis and Helicobacter pylori infection in primary biliary cirrhosis. Dig Dis Sci 47(1):162\u2013169. doi: 10.1023\/A:1013292210036","journal-title":"Dig Dis Sci"},{"issue":"4","key":"164_CR140","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0168-8278(94)80117-7","volume":"21","author":"L Vilagut","year":"1994","unstructured":"Vilagut L et al (1994) Cross-reactivity of anti-Mycobacterium gordonae antibodies with the major mitochondrial autoantigens in primary biliary cirrhosis. J Hepatol 21(4):673\u2013677. doi: 10.1016\/S0168-8278(94)80117-7","journal-title":"J Hepatol"},{"issue":"3","key":"164_CR141","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jhep.2008.05.022","volume":"49","author":"D Bogdanos","year":"2008","unstructured":"Bogdanos D et al (2008) Primary biliary cirrhosis following Lactobacillus vaccination for recurrent vaginitis. J Hepatol 49(3):466\u2013473. doi: 10.1016\/j.jhep.2008.05.022","journal-title":"J Hepatol"},{"issue":"14","key":"164_CR142","doi-asserted-by":"crossref","first-page":"8454","DOI":"10.1073\/pnas.1433063100","volume":"100","author":"L Xu","year":"2003","unstructured":"Xu L et al (2003) Does a betaretrovirus infection trigger primary biliary cirrhosis? Proc Natl Acad Sci U S A 100(14):8454\u20138459. doi: 10.1073\/pnas.1433063100","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"164_CR143","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/hep.20024","volume":"39","author":"L Xu","year":"2004","unstructured":"Xu L et al (2004) Cloning the human betaretrovirus proviral genome from patients with primary biliary cirrhosis. Hepatology 39(1):151\u2013156. doi: 10.1002\/hep.20024","journal-title":"Hepatology"},{"issue":"1","key":"164_CR144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198201073060101","volume":"306","author":"J Neuberger","year":"1982","unstructured":"Neuberger J et al (1982) Recurrence of primary biliary cirrhosis after liver transplantation. N Engl J Med 306(1):1\u20134","journal-title":"N Engl J Med"},{"issue":"5","key":"164_CR145","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/hep.510240517","volume":"24","author":"Van de Water J, et al","year":"1996","unstructured":"Van de Water J et al (1996) Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis. Hepatology 24(5):1079\u20131084. doi: 10.1002\/hep.510240517","journal-title":"Hepatology"},{"issue":"4","key":"164_CR146","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/hep.21624","volume":"45","author":"H Robertson","year":"2007","unstructured":"Robertson H et al (2007) Biliary epithelial\u2013mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis. Hepatology 45(4):977\u2013981. doi: 10.1002\/hep.21624","journal-title":"Hepatology"},{"issue":"9081","key":"164_CR147","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(97)05419-6","volume":"350","author":"J Neuberger","year":"1997","unstructured":"Neuberger J (1997) Primary biliary cirrhosis. Lancet 350(9081):875\u2013879. doi: 10.1016\/S0140-6736(97)05419-6","journal-title":"Lancet"},{"issue":"4","key":"164_CR148","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3109\/07435808909036347","volume":"15","author":"C Scheidereit","year":"1989","unstructured":"Scheidereit C et al (1989) Protein\u2013DNA interactions at steroid hormone regulated genes. Endocr Res 15(4):417\u2013440","journal-title":"Endocr Res"},{"issue":"9405","key":"164_CR149","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(03)15418-9","volume":"363","author":"R Poupon","year":"2004","unstructured":"Poupon R, Poupon RE (2004) Retrovirus infection as a trigger for primary biliary cirrhosis? Lancet 363(9405):260\u2013261. doi: 10.1016\/S0140-6736(03)15418-9","journal-title":"Lancet"},{"issue":"12","key":"164_CR150","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1111\/j.1572-0241.2004.40741.x","volume":"99","author":"AL Mason","year":"2004","unstructured":"Mason AL et al (2004) Pilot studies of single and combination antiretroviral therapy in patients with primary biliary cirrhosis. Am J Gastroenterol 99(12):2348\u20132355. doi: 10.1111\/j.1572-0241.2004.40741.x","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"164_CR151","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1111\/j.1572-0241.2004.41157.x","volume":"99","author":"ME Gershwin","year":"2004","unstructured":"Gershwin ME, Selmi C (2004) Apocalypsal versus apocryphal: the role of retroviruses in primary biliary cirrhosis. Am J Gastroenterol 99(12):2356\u20132358. doi: 10.1111\/j.1572-0241.2004.41157.x","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"164_CR152","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/j.gastro.2004.05.033","volume":"127","author":"C Selmi","year":"2004","unstructured":"Selmi C et al (2004) Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis. Gastroenterology 127(2):493\u2013501. doi: 10.1053\/j.gastro.2004.05.033","journal-title":"Gastroenterology"},{"key":"164_CR153","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2741\/1230","volume":"9","author":"CL Cooper","year":"2004","unstructured":"Cooper CL et al (2004) Antiretroviral therapy influences cellular susceptibility to apoptosis in vivo. Front Biosci 9:338\u2013341. doi: 10.2741\/1230","journal-title":"Front Biosci"},{"issue":"4","key":"164_CR154","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2036.2007.03402.x","volume":"26","author":"J McDermid","year":"2007","unstructured":"McDermid J et al (2007) Reverse transcriptase activity in patients with primary biliary cirrhosis and other autoimmune liver disorders. Aliment Pharmacol Ther 26(4):587\u2013595","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"164_CR155","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1053\/jhep.2001.21165","volume":"33","author":"A Parikh-Patel","year":"2001","unstructured":"Parikh-Patel A et al (2001) Risk factors for primary biliary cirrhosis in a cohort of patients from the United States. Hepatology 33(1):16\u201321. doi: 10.1053\/jhep.2001.21165","journal-title":"Hepatology"},{"issue":"5","key":"164_CR156","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1053\/he.2000.7050","volume":"31","author":"D Howel","year":"2000","unstructured":"Howel D et al (2000) An exploratory population-based case\u2013control study of primary biliary cirrhosis. Hepatology 31(5):1055\u20131060. doi: 10.1053\/he.2000.7050","journal-title":"Hepatology"},{"issue":"5","key":"164_CR157","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/00365520500319633","volume":"41","author":"EI Rigopoulou","year":"2006","unstructured":"Rigopoulou EI et al (2006) Lack of association between appendectomy and primary biliary cirrhosis. Scand J Gastroenterol 41(5):573\u2013576. doi: 10.1080\/00365520500319633","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"164_CR158","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0168-8278(01)00252-5","volume":"36","author":"DP Bogdanos","year":"2002","unstructured":"Bogdanos DP et al (2002) Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis. J Hepatol 36(1):14\u201321. doi: 10.1016\/S0168-8278(01)00252-5","journal-title":"J Hepatol"},{"issue":"12","key":"164_CR159","first-page":"766","volume":"57","author":"RS Bennion","year":"1991","unstructured":"Bennion RS et al (1991) The role of Yersinia enterocolitica in appendicitis in the southwestern United States. Am Surg 57(12):766\u2013768","journal-title":"Am Surg"},{"issue":"4","key":"164_CR160","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jaut.2007.07.017","volume":"29","author":"Y Peng","year":"2007","unstructured":"Peng Y et al (2007) Innate and adaptive immune response to apoptotic cells. J Autoimmun 29(4):303\u2013309. doi: 10.1016\/j.jaut.2007.07.017","journal-title":"J Autoimmun"},{"issue":"4","key":"164_CR161","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/1074-7613(95)90180-9","volume":"3","author":"DM Willerford","year":"1995","unstructured":"Willerford DM et al (1995) Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3(4):521\u2013530. doi: 10.1016\/1074-7613(95)90180-9","journal-title":"Immunity"},{"issue":"6","key":"164_CR162","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0092-8674(87)90507-1","volume":"50","author":"MB Oldstone","year":"1987","unstructured":"Oldstone MB (1987) Molecular mimicry and autoimmune disease. Cell 50(6):819\u2013820. doi: 10.1016\/0092-8674(87)90507-1","journal-title":"Cell"},{"key":"164_CR163","first-page":"67","volume":"206","author":"MB Oldstone","year":"1996","unstructured":"Oldstone MB et al (1996) Virus-induced autoimmune disease: transgenic approach to mimic insulin-dependent diabetes mellitus and multiple sclerosis. Curr Top Microbiol Immunol 206:67\u201383","journal-title":"Curr Top Microbiol Immunol"},{"issue":"2","key":"164_CR164","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ana.410390213","volume":"39","author":"PJ Talbot","year":"1996","unstructured":"Talbot PJ et al (1996) Myelin basic protein and human coronavirus 229E cross-reactive T cells in multiple sclerosis. Ann Neurol 39(2):233\u2013240. doi: 10.1002\/ana.410390213","journal-title":"Ann Neurol"},{"issue":"5","key":"164_CR165","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0092-8674(95)90348-8","volume":"80","author":"KW Wucherpfennig","year":"1995","unstructured":"Wucherpfennig KW, Strominger JL (1995) Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80(5):695\u2013705. doi: 10.1016\/0092-8674(95)90348-8","journal-title":"Cell"},{"issue":"1","key":"164_CR166","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/08916930500484849","volume":"39","author":"BD Poole","year":"2006","unstructured":"Poole BD et al (2006) Epstein\u2013Barr virus and molecular mimicry in systemic lupus erythematosus. Autoimmunity 39(1):63\u201370. doi: 10.1080\/08916930500484849","journal-title":"Autoimmunity"},{"key":"164_CR167","first-page":"27","volume":"145","author":"W Eden van","year":"1989","unstructured":"van Eden W et al (1989) A cartilage-mimicking T-cell epitope on a 65\u00a0K mycobacterial heat-shock protein: adjuvant arthritis as a model for human rheumatoid arthritis. Curr Top Microbiol Immunol 145:27\u201343","journal-title":"Curr Top Microbiol Immunol"},{"issue":"12","key":"164_CR168","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMra020100","volume":"347","author":"JF Bach","year":"2002","unstructured":"Bach JF (2002) The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347(12):911\u2013920. doi: 10.1056\/NEJMra020100","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"164_CR169","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2005.09.024","volume":"25","author":"JF Bach","year":"2005","unstructured":"Bach JF (2005) Infections and autoimmune diseases. J Autoimmun 25(Suppl):74\u201380. doi: 10.1016\/j.jaut.2005.09.024","journal-title":"J Autoimmun"},{"issue":"5","key":"164_CR170","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.autrev.2004.12.001","volume":"4","author":"S Havarinasab","year":"2005","unstructured":"Havarinasab S, Hultman P (2005) Organic mercury compounds and autoimmunity. Autoimmun Rev 4(5):270\u2013275. doi: 10.1016\/j.autrev.2004.12.001","journal-title":"Autoimmun Rev"},{"key":"164_CR171","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1196\/annals.1422.019","volume":"1108","author":"AT Borchers","year":"2007","unstructured":"Borchers AT, Keen CL, Gershwin ME (2007) Drug-induced lupus. Ann N Y Acad Sci 1108:166\u2013182. doi: 10.1196\/annals.1422.019","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"164_CR172","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0889-857X(21)00226-X","volume":"20","author":"RL Yung","year":"1994","unstructured":"Yung RL, Richardson BC (1994) Drug-induced lupus. Rheum Dis Clin North Am 20(1):61\u201386","journal-title":"Rheum Dis Clin North Am"},{"issue":"1\u20132","key":"164_CR173","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1568-9972(01)00016-7","volume":"1","author":"NR Rose","year":"2002","unstructured":"Rose NR, Bonita R, Burek CL (2002) Iodine: an environmental trigger of thyroiditis. Autoimmun Rev 1(1\u20132):97\u2013103. doi: 10.1016\/S1568-9972(01)00016-7","journal-title":"Autoimmun Rev"},{"key":"164_CR174","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-642-46856-8_1","volume":"20","author":"J Gut","year":"1998","unstructured":"Gut J (1998) Molecular basis of halothane hepatitis. Arch Toxicol Suppl 20:3\u201317","journal-title":"Arch Toxicol Suppl"},{"issue":"3","key":"164_CR175","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S1089-3261(02)00025-9","volume":"6","author":"ZX Liu","year":"2002","unstructured":"Liu ZX, Kaplowitz N (2002) Immune-mediated drug-induced liver disease. Clin Liver Dis 6(3):755\u2013774. doi: 10.1016\/S1089-3261(02)00025-9","journal-title":"Clin Liver Dis"},{"issue":"3","key":"164_CR176","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1432-1033.1994.tb19082.x","volume":"223","author":"U Christen","year":"1994","unstructured":"Christen U et al (1994) Identification of the dihydrolipoamide acetyltransferase subunit of the human pyruvate dehydrogenase complex as an autoantigen in halothane hepatitis. Molecular mimicry of trifluoroacetyl-lysine by lipoic acid. Eur J Biochem 223(3):1035\u20131047. doi: 10.1111\/j.1432-1033.1994.tb19082.x","journal-title":"Eur J Biochem"},{"issue":"5302","key":"164_CR177","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1126\/science.275.5302.960","volume":"275","author":"C Giordano","year":"1997","unstructured":"Giordano C et al (1997) Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275(5302):960\u2013963","journal-title":"Science"},{"issue":"1\u20132","key":"164_CR178","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jaut.2007.11.009","volume":"30","author":"IR Mackay","year":"2008","unstructured":"Mackay IR, Leskovsek NV, Rose NR (2008) Cell damage and autoimmunity: a critical appraisal. J Autoimmun 30(1\u20132):5\u201311. doi: 10.1016\/j.jaut.2007.11.009","journal-title":"J Autoimmun"},{"issue":"6","key":"164_CR179","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jhep.2008.09.010","volume":"49","author":"U Beuers","year":"2008","unstructured":"Beuers U, Oude-Elferink RP (2008) New light on anion exchangers in primary biliary cirrhosis. J Hepatol 49(6):881\u2013883. doi: 10.1016\/j.jhep.2008.09.010","journal-title":"J Hepatol"},{"issue":"5","key":"164_CR180","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/hep.510250505","volume":"25","author":"H Koga","year":"1997","unstructured":"Koga H et al (1997) Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis. Hepatology 25(5):1077\u20131084. doi: 10.1002\/hep.510250505","journal-title":"Hepatology"},{"issue":"3","key":"164_CR181","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.0106-9543.2002.01595.x","volume":"22","author":"J Tinmouth","year":"2002","unstructured":"Tinmouth J et al (2002) Apoptosis of biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis. Liver 22(3):228\u2013234. doi: 10.1046\/j.0106-9543.2002.01595.x","journal-title":"Liver"},{"issue":"2","key":"164_CR182","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1053\/j.gastro.2006.05.056","volume":"131","author":"S Shimoda","year":"2006","unstructured":"Shimoda S et al (2006) Autoreactive T-cell responses in primary biliary cirrhosis are proinflammatory whereas those of controls are regulatory. Gastroenterology 131(2):606\u2013618. doi: 10.1053\/j.gastro.2006.05.056","journal-title":"Gastroenterology"},{"issue":"1","key":"164_CR183","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2007.05.002","volume":"29","author":"WW Eaton","year":"2007","unstructured":"Eaton WW et al (2007) Epidemiology of autoimmune diseases in Denmark. J Autoimmun 29(1):1\u20139. doi: 10.1016\/j.jaut.2007.05.002","journal-title":"J Autoimmun"},{"issue":"4","key":"164_CR184","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/hep.510290403","volume":"29","author":"L Dubel","year":"1999","unstructured":"Dubel L et al (1999) Autoepitope mapping and reactivity of autoantibodies to the dihydrolipoamide dehydrogenase-binding protein (E3BP) and the glycine cleavage proteins in primary biliary cirrhosis. Hepatology 29(4):1013\u20131018. doi: 10.1002\/hep.510290403","journal-title":"Hepatology"},{"issue":"6","key":"164_CR185","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1084\/jem.167.6.1791","volume":"167","author":"Van de Water J, et al","year":"1988","unstructured":"Van de Water J et al (1988) The autoepitope of the 74-kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase. J Exp Med 167(6):1791\u20131799. doi: 10.1084\/jem.167.6.1791","journal-title":"J Exp Med"},{"issue":"2","key":"164_CR186","first-page":"505","volume":"22","author":"PS Leung","year":"1995","unstructured":"Leung PS et al (1995) Autoantibodies to BCOADC-E2 in patients with primary biliary cirrhosis recognize a conformational epitope. Hepatology 22(2):505\u2013513","journal-title":"Hepatology"},{"issue":"3","key":"164_CR187","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/hep.510230307","volume":"23","author":"S Moteki","year":"1996","unstructured":"Moteki S et al (1996) Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex. Hepatology 23(3):436\u2013444. doi: 10.1002\/hep.510230307","journal-title":"Hepatology"},{"issue":"9","key":"164_CR188","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.4049\/jimmunol.144.9.3367","volume":"144","author":"CD Surh","year":"1990","unstructured":"Surh CD, Coppel R, Gershwin ME (1990) Structural requirement for autoreactivity on human pyruvate dehydrogenase-E2, the major autoantigen of primary biliary cirrhosis. Implication for a conformational autoepitope. J Immunol 144(9):3367\u20133374","journal-title":"J Immunol"},{"issue":"9","key":"164_CR189","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1172\/JCI0214698","volume":"109","author":"H Kita","year":"2002","unstructured":"Kita H et al (2002) Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J Clin Invest 109(9):1231\u20131240","journal-title":"J Clin Invest"},{"issue":"4","key":"164_CR190","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1053\/gast.2002.36020","volume":"123","author":"H Kita","year":"2002","unstructured":"Kita H et al (2002) Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology 123(4):1031\u20131043. doi: 10.1053\/gast.2002.36020","journal-title":"Gastroenterology"},{"issue":"10","key":"164_CR191","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1172\/JCI4213","volume":"102","author":"S Shimoda","year":"1998","unstructured":"Shimoda S et al (1998) Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J Clin Invest 102(10):1831\u20131840. doi: 10.1172\/JCI4213","journal-title":"J Clin Invest"},{"issue":"4 Pt 1","key":"164_CR192","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1053\/jhep.2002.35616","volume":"36","author":"H Kita","year":"2002","unstructured":"Kita H et al (2002) Analysis of TCR antagonism and molecular mimicry of an HLA-A0201-restricted CTL epitope in primary biliary cirrhosis. Hepatology 36(4 Pt 1):918\u2013926","journal-title":"Hepatology"},{"issue":"5","key":"164_CR193","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.4049\/jimmunol.167.5.2956","volume":"167","author":"SA Long","year":"2001","unstructured":"Long SA et al (2001) Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis. J Immunol 167(5):2956\u20132963","journal-title":"J Immunol"},{"issue":"10","key":"164_CR194","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.4049\/jimmunol.170.10.5326","volume":"170","author":"PS Leung","year":"2003","unstructured":"Leung PS et al (2003) Immunization with a xenobiotic 6-bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies. J Immunol 170(10):5326\u20135332","journal-title":"J Immunol"},{"issue":"4","key":"164_CR195","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.4049\/jimmunol.179.4.2651","volume":"179","author":"PS Leung","year":"2007","unstructured":"Leung PS et al (2007) Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization. J Immunol 179(4):2651\u20132657","journal-title":"J Immunol"},{"issue":"2","key":"164_CR196","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/hep.22390","volume":"48","author":"K Wakabayashi","year":"2008","unstructured":"Wakabayashi K et al (2008) Loss of tolerance in C57BL\/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology 48(2):531\u2013540. doi: 10.1002\/hep.22390","journal-title":"Hepatology"},{"issue":"4","key":"164_CR197","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/hep.21123","volume":"43","author":"RY Lan","year":"2006","unstructured":"Lan RY et al (2006) Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology 43(4):729\u2013737. doi: 10.1002\/hep.21123","journal-title":"Hepatology"},{"issue":"3","key":"164_CR198","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.4049\/jimmunol.177.3.1655","volume":"177","author":"S Oertelt","year":"2006","unstructured":"Oertelt S et al (2006) Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice. J Immunol 177(3):1655\u20131660","journal-title":"J Immunol"},{"issue":"5","key":"164_CR199","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/hep.21385","volume":"44","author":"K Wakabayashi","year":"2006","unstructured":"Wakabayashi K et al (2006) IL-2 receptor alpha(\u2212\/\u2212) mice and the development of primary biliary cirrhosis. Hepatology 44(5):1240\u20131249. doi: 10.1002\/hep.21385","journal-title":"Hepatology"},{"issue":"3","key":"164_CR200","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1053\/j.gastro.2008.11.035","volume":"136","author":"Y Moritoki","year":"2009","unstructured":"Moritoki Y et al (2009) B cells suppress the inflammatory response in a mouse model of primary biliary cirrhosis. Gastroenterology 136(3):1037\u20131047. doi: 10.1053\/j.gastro.2008.11.035","journal-title":"Gastroenterology"},{"issue":"1","key":"164_CR201","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jaut.2006.04.005","volume":"27","author":"CA Aoki","year":"2006","unstructured":"Aoki CA et al (2006) IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J Autoimmun 27(1):50\u201353. doi: 10.1016\/j.jaut.2006.04.005","journal-title":"J Autoimmun"},{"issue":"5","key":"164_CR202","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1084\/jem.20051911","volume":"203","author":"J Irie","year":"2006","unstructured":"Irie J et al (2006) NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis. J Exp Med 203(5):1209\u20131219. doi: 10.1084\/jem.20051911","journal-title":"J Exp Med"},{"issue":"1","key":"164_CR203","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jaut.2008.11.001","volume":"32","author":"RY Lan","year":"2009","unstructured":"Lan RY et al (2009) Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J Autoimmun 32(1):43\u201351. doi: 10.1016\/j.jaut.2008.11.001","journal-title":"J Autoimmun"},{"issue":"5","key":"164_CR204","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1053\/j.gastro.2008.02.020","volume":"134","author":"JT Salas","year":"2008","unstructured":"Salas JT et al (2008) Ae2a, b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis. Gastroenterology 134(5):1482\u20131493. doi: 10.1053\/j.gastro.2008.02.020","journal-title":"Gastroenterology"},{"issue":"6","key":"164_CR205","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/hep.510280601","volume":"28","author":"U Beuers","year":"1998","unstructured":"Beuers U, Boyer JL, Paumgartner G (1998) Ursodeoxycholic acid in cholestasis: potential mechanisms of action and therapeutic applications. Hepatology 28(6):1449\u20131453. doi: 10.1002\/hep.510280601","journal-title":"Hepatology"},{"issue":"10","key":"164_CR206","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.4049\/jimmunol.161.10.5157","volume":"161","author":"C Migliaccio","year":"1998","unstructured":"Migliaccio C et al (1998) Monoclonal antibodies to mitochondrial E2 components define autoepitopes in primary biliary cirrhosis. J Immunol 161(10):5157\u20135163","journal-title":"J Immunol"},{"issue":"4","key":"164_CR207","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1053\/jhep.2001.23783","volume":"33","author":"C Migliaccio","year":"2001","unstructured":"Migliaccio C et al (2001) Heterogeneous response of antimitochondrial autoantibodies and bile duct apical staining monoclonal antibodies to pyruvate dehydrogenase complex E2: the molecule versus the mimic. Hepatology 33(4):792\u2013801. doi: 10.1053\/jhep.2001.23783","journal-title":"Hepatology"},{"key":"164_CR208","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1034\/j.1600-0528.2002.017402.x","volume":"174","author":"ME Gershwin","year":"2000","unstructured":"Gershwin ME et al (2000) Primary biliary cirrhosis: an orchestrated immune response against epithelial cells. Immunol Rev 174:210\u2013225. doi: 10.1034\/j.1600-0528.2002.017402.x","journal-title":"Immunol Rev"},{"issue":"6","key":"164_CR209","first-page":"1383","volume":"36","author":"N Fukushima","year":"2002","unstructured":"Fukushima N et al (2002) Characterization of recombinant monoclonal IgA anti-PDC-E2 autoantibodies derived from patients with PBC. Hepatology 36(6):1383\u20131392","journal-title":"Hepatology"},{"issue":"5","key":"164_CR210","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1006\/jaut.1998.0220","volume":"11","author":"AC Malmborg","year":"1998","unstructured":"Malmborg AC et al (1998) Penetration and co-localization in MDCK cell mitochondria of IgA derived from patients with primary biliary cirrhosis. J Autoimmun 11(5):573\u2013580. doi: 10.1006\/jaut.1998.0220","journal-title":"J Autoimmun"},{"issue":"2","key":"164_CR211","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1172\/JCI200110716","volume":"108","author":"JA Odin","year":"2001","unstructured":"Odin JA et al (2001) Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest 108(2):223\u2013232","journal-title":"J Clin Invest"},{"issue":"4","key":"164_CR212","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jaut.2006.11.004","volume":"27","author":"J Allina","year":"2006","unstructured":"Allina J et al (2006) T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis. J Autoimmun 27(4):232\u2013241. doi: 10.1016\/j.jaut.2006.11.004","journal-title":"J Autoimmun"},{"issue":"7","key":"164_CR213","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/BF01308413","volume":"30","author":"U Leuschner","year":"1985","unstructured":"Leuschner U et al (1985) Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study. Dig Dis Sci 30(7):642\u2013649. doi: 10.1007\/BF01308413","journal-title":"Dig Dis Sci"},{"issue":"8537","key":"164_CR214","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0140-6736(87)91610-2","volume":"1","author":"R Poupon","year":"1987","unstructured":"Poupon R et al (1987) Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? Lancet 1(8537):834\u2013836. doi: 10.1016\/S0140-6736(87)91610-2","journal-title":"Lancet"},{"issue":"5","key":"164_CR215","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/0016-5085(89)91698-3","volume":"97","author":"U Leuschner","year":"1989","unstructured":"Leuschner U et al (1989) Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial. Gastroenterology 97(5):1268\u20131274","journal-title":"Gastroenterology"},{"issue":"22","key":"164_CR216","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJM199105303242204","volume":"324","author":"RE Poupon","year":"1991","unstructured":"Poupon RE et al (1991) A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group. N Engl J Med 324(22):1548\u20131554","journal-title":"N Engl J Med"},{"issue":"5","key":"164_CR217","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/hep.1840190512","volume":"19","author":"EJ Heathcote","year":"1994","unstructured":"Heathcote EJ et al (1994) The Canadian Multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 19(5):1149\u20131156. doi: 10.1002\/hep.1840190512","journal-title":"Hepatology"},{"issue":"5","key":"164_CR218","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/0016-5085(94)90021-3","volume":"106","author":"KD Lindor","year":"1994","unstructured":"Lindor KD et al (1994) Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 106(5):1284\u20131290","journal-title":"Gastroenterology"},{"issue":"4","key":"164_CR219","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0168-8278(00)80216-0","volume":"32","author":"A Pares","year":"2000","unstructured":"Pares A et al (2000) Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA\u2013 Cooperative Group from the Spanish Association for the Study of the Liver. J Hepatol 32(4):561\u2013566. doi: 10.1016\/S0168-8278(00)80216-0","journal-title":"J Hepatol"},{"issue":"3","key":"164_CR220","first-page":"759","volume":"22","author":"B Combes","year":"1995","unstructured":"Combes B et al (1995) A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 22(3):759\u2013766","journal-title":"Hepatology"},{"issue":"6","key":"164_CR221","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1053\/jhep.2000.20240","volume":"32","author":"C Corpechot","year":"2000","unstructured":"Corpechot C et al (2000) The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis. Hepatology 32(6):1196\u20131199. doi: 10.1053\/jhep.2000.20240","journal-title":"Hepatology"},{"issue":"3","key":"164_CR222","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0016-5085(97)70183-5","volume":"113","author":"RE Poupon","year":"1997","unstructured":"Poupon RE et al (1997) Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 113(3):884\u2013890. doi: 10.1016\/S0016-5085(97)70183-5","journal-title":"Gastroenterology"},{"issue":"10","key":"164_CR223","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1046\/j.1365-2036.2003.01792.x","volume":"18","author":"W Hempfling","year":"2003","unstructured":"Hempfling W, Dilger K, Beuers U (2003) Systematic review: ursodeoxycholic acid-adverse effects and drug interactions. Aliment Pharmacol Ther 18(10):963\u2013972. doi: 10.1046\/j.1365-2036.2003.01792.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"164_CR224","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/ncpgasthep0521","volume":"3","author":"U Beuers","year":"2006","unstructured":"Beuers U (2006) Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat Clin Pract Gastroenterol Hepatol 3(6):318\u2013328. doi: 10.1038\/ncpgasthep0521","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"issue":"1","key":"164_CR225","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cld.2007.11.013","volume":"12","author":"G Paumgartner","year":"2008","unstructured":"Paumgartner G, Pusl T (2008) Medical treatment of cholestatic liver disease. Clin Liver Dis 12(1):53\u201380. doi: 10.1016\/j.cld.2007.11.013","journal-title":"Clin Liver Dis"},{"issue":"3","key":"164_CR226","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/jhep.2002.36088","volume":"36","author":"G Paumgartner","year":"2002","unstructured":"Paumgartner G, Beuers U (2002) Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology 36(3):525\u2013531. doi: 10.1053\/jhep.2002.36088","journal-title":"Hepatology"},{"issue":"2","key":"164_CR227","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2174\/157488407780598171","volume":"2","author":"D Festi","year":"2007","unstructured":"Festi D et al (2007) Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases. Curr Clin Pharmacol 2(2):155\u2013177. doi: 10.2174\/157488407780598171","journal-title":"Curr Clin Pharmacol"},{"issue":"2","key":"164_CR228","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.gastro.2005.05.009","volume":"129","author":"HU Marschall","year":"2005","unstructured":"Marschall HU et al (2005) Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans. Gastroenterology 129(2):476\u2013485","journal-title":"Gastroenterology"},{"issue":"3","key":"164_CR229","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/hep.20568","volume":"41","author":"K Dilger","year":"2005","unstructured":"Dilger K et al (2005) No relevant effect of ursodeoxycholic acid on cytochrome P450 3A metabolism in primary biliary cirrhosis. Hepatology 41(3):595\u2013602. doi: 10.1002\/hep.20568","journal-title":"Hepatology"},{"issue":"4","key":"164_CR230","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/hep.1840170412","volume":"17","author":"RE Poupon","year":"1993","unstructured":"Poupon RE et al (1993) Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid therapy. Hepatology 17(4):599\u2013604. doi: 10.1002\/hep.1840170412","journal-title":"Hepatology"},{"issue":"1","key":"164_CR231","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0016-5085(94)94899-2","volume":"106","author":"RP Jazrawi","year":"1994","unstructured":"Jazrawi RP et al (1994) Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid. Gastroenterology 106(1):134\u2013142","journal-title":"Gastroenterology"},{"issue":"6","key":"164_CR232","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1172\/JCI116921","volume":"92","author":"U Beuers","year":"1993","unstructured":"Beuers U et al (1993) Tauroursodeoxycholic acid stimulates hepatocellular exocytosis and mobilizes extracellular Ca++ mechanisms defective in cholestasis. J Clin Invest 92(6):2984\u20132993. doi: 10.1172\/JCI116921","journal-title":"J Clin Invest"},{"issue":"5","key":"164_CR233","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1053\/jhep.2001.24034","volume":"33","author":"U Beuers","year":"2001","unstructured":"Beuers U et al (2001) Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver. Hepatology 33(5):1206\u20131216. doi: 10.1053\/jhep.2001.24034","journal-title":"Hepatology"},{"issue":"2","key":"164_CR234","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/labinvest.3700371","volume":"86","author":"F Dombrowski","year":"2006","unstructured":"Dombrowski F, Stieger B, Beuers U (2006) Tauroursodeoxycholic acid inserts the bile salt export pump into canalicular membranes of cholestatic rat liver. Lab Invest 86(2):166\u2013174. doi: 10.1038\/labinvest.3700371","journal-title":"Lab Invest"},{"issue":"10","key":"164_CR235","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1136\/gut.2007.140871","volume":"57","author":"R Wimmer","year":"2008","unstructured":"Wimmer R et al (2008) Tauroursodeoxycholic acid exerts anticholestatic effects by a cooperative cPKC alpha-\/PKA-dependent mechanism in rat liver. Gut 57(10):1448\u20131454. doi: 10.1136\/gut.2007.140871","journal-title":"Gut"},{"issue":"5","key":"164_CR236","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/S0016-5085(03)00274-9","volume":"124","author":"D Haussinger","year":"2003","unstructured":"Haussinger D et al (2003) Involvement of integrins and Src in tauroursodeoxycholate-induced and swelling-induced choleresis. Gastroenterology 124(5):1476\u20131487. doi: 10.1016\/S0016-5085(03)00274-9","journal-title":"Gastroenterology"},{"issue":"2","key":"164_CR237","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2003.11.003","volume":"126","author":"R Kubitz","year":"2004","unstructured":"Kubitz R et al (2004) Trafficking of the bile salt export pump from the Golgi to the canalicular membrane is regulated by the p38 MAP kinase. Gastroenterology 126(2):541\u2013553. doi: 10.1053\/j.gastro.2003.11.003","journal-title":"Gastroenterology"},{"key":"164_CR238","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1872-034X.2008.00321.x","volume":"38","author":"GU Denk","year":"2008","unstructured":"Denk GU et al (2008) Role of mitogen-activated protein kinases in tauroursodeoxycholic acid-induced bile formation in cholestatic rat liver. Hepatol Res 38:717\u2013726","journal-title":"Hepatol Res"},{"issue":"5","key":"164_CR239","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1053\/jhep.2001.24171","volume":"33","author":"J Noe","year":"2001","unstructured":"Noe J et al (2001) Characterization of the mouse bile salt export pump overexpressed in the baculovirus system. Hepatology 33(5):1223\u20131231. doi: 10.1053\/jhep.2001.24171","journal-title":"Hepatology"},{"issue":"2","key":"164_CR240","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0016-5085(93)90735-U","volume":"105","author":"J Prieto","year":"1993","unstructured":"Prieto J et al (1993) Abnormal expression of anion exchanger genes in primary biliary cirrhosis. Gastroenterology 105(2):572\u2013578","journal-title":"Gastroenterology"},{"issue":"1","key":"164_CR241","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0016-5085(99)70564-0","volume":"117","author":"J Prieto","year":"1999","unstructured":"Prieto J et al (1999) Assessment of biliary bicarbonate secretion in humans by positron emission tomography. Gastroenterology 117(1):167\u2013172. doi: 10.1016\/S0016-5085(99)70564-0","journal-title":"Gastroenterology"},{"issue":"1","key":"164_CR242","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hep.510250104","volume":"25","author":"JF Medina","year":"1997","unstructured":"Medina JF et al (1997) Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis. Hepatology 25(1):12\u201317. doi: 10.1002\/hep.510250104","journal-title":"Hepatology"},{"issue":"9","key":"164_CR243","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/j.1572-0241.1998.00470.x","volume":"93","author":"KD Lindor","year":"1998","unstructured":"Lindor KD et al (1998) Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis. Am J Gastroenterol 93(9):1498\u20131504. doi: 10.1111\/j.1572-0241.1998.00470.x","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"164_CR244","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/hep.20370","volume":"40","author":"D Rost","year":"2004","unstructured":"Rost D et al (2004) Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis. Hepatology 40(3):693\u2013698. doi: 10.1002\/hep.20370","journal-title":"Hepatology"},{"issue":"7","key":"164_CR245","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S1590-8658(02)80112-8","volume":"34","author":"E Roda","year":"2002","unstructured":"Roda E et al (2002) Improved liver tests and greater biliary enrichment with high dose ursodeoxycholic acid in early stage primary biliary cirrhosis. Dig Liver Dis 34(7):523\u2013527. doi: 10.1016\/S1590-8658(02)80112-8","journal-title":"Dig Liver Dis"},{"issue":"3","key":"164_CR246","first-page":"283","volume":"23","author":"A Stiehl","year":"1995","unstructured":"Stiehl A et al (1995) Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment. J Hepatol 23(3):283\u2013289","journal-title":"J Hepatol"},{"issue":"12","key":"164_CR247","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1172\/JCI1325","volume":"101","author":"CM Rodrigues","year":"1998","unstructured":"Rodrigues CM et al (1998) A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J Clin Invest 101(12):2790\u20132799. doi: 10.1172\/JCI1325","journal-title":"J Clin Invest"},{"issue":"3","key":"164_CR248","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0168-8278(02)00209-X","volume":"37","author":"JH Yoon","year":"2002","unstructured":"Yoon JH, Gores GJ (2002) Death receptor-mediated apoptosis and the liver. J Hepatol 37(3):400\u2013410. doi: 10.1016\/S0168-8278(02)00209-X","journal-title":"J Hepatol"},{"issue":"3","key":"164_CR249","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF03401914","volume":"4","author":"CM Rodrigues","year":"1998","unstructured":"Rodrigues CM et al (1998) Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol Med 4(3):165\u2013178","journal-title":"Mol Med"},{"issue":"5","key":"164_CR250","doi-asserted-by":"crossref","first-page":"G734","DOI":"10.1152\/ajpgi.00491.2002","volume":"284","author":"H Higuchi","year":"2003","unstructured":"Higuchi H, Gores GJ (2003) Bile acid regulation of hepatic physiology: IV. Bile acids and death receptors. Am J Physiol Gastrointest Liver Physiol 284(5):G734\u2013G738","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"3","key":"164_CR251","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0016-5085(03)01055-2","volume":"125","author":"R Reinehr","year":"2003","unstructured":"Reinehr R, Graf D, Haussinger D (2003) Bile salt-induced hepatocyte apoptosis involves epidermal growth factor receptor-dependent CD95 tyrosine phosphorylation. Gastroenterology 125(3):839\u2013853. doi: 10.1016\/S0016-5085(03)01055-2","journal-title":"Gastroenterology"},{"issue":"6","key":"164_CR252","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/hep.20246","volume":"39","author":"MH Schoemaker","year":"2004","unstructured":"Schoemaker MH et al (2004) Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways. Hepatology 39(6):1563\u20131573. doi: 10.1002\/hep.20246","journal-title":"Hepatology"},{"issue":"5","key":"164_CR253","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1074\/jbc.M804585200","volume":"284","author":"C Rust","year":"2009","unstructured":"Rust C et al (2009) Bile acid-induced apoptosis in hepatocytes is caspase-6-dependent. J Biol Chem 284(5):2908\u20132916. doi: 10.1074\/jbc.M804585200","journal-title":"J Biol Chem"},{"issue":"3","key":"164_CR254","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2362.2000.00615.x","volume":"30","author":"C Benz","year":"2000","unstructured":"Benz C et al (2000) Effect of tauroursodeoxycholic acid on bile acid-induced apoptosis in primary human hepatocytes. Eur J Clin Invest 30(3):203\u2013209. doi: 10.1046\/j.1365-2362.2000.00615.x","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"164_CR255","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.gastro.2004.04.009","volume":"127","author":"P Fickert","year":"2004","unstructured":"Fickert P et al (2004) Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology 127(1):261\u2013274. doi: 10.1053\/j.gastro.2004.04.009","journal-title":"Gastroenterology"},{"issue":"4","key":"164_CR256","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1053\/j.gastro.2005.01.007","volume":"128","author":"G Svegliati-Baroni","year":"2005","unstructured":"Svegliati-Baroni G et al (2005) Bile acids induce hepatic stellate cell proliferation via activation of the epidermal growth factor receptor. Gastroenterology 128(4):1042\u20131055. doi: 10.1053\/j.gastro.2005.01.007","journal-title":"Gastroenterology"},{"issue":"5","key":"164_CR257","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1053\/j.gastro.2004.08.001","volume":"127","author":"S Fiorucci","year":"2004","unstructured":"Fiorucci S et al (2004) The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis. Gastroenterology 127(5):1497\u20131512. doi: 10.1053\/j.gastro.2004.08.001","journal-title":"Gastroenterology"},{"issue":"2","key":"164_CR258","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1053\/j.gastro.2005.10.018","volume":"130","author":"P Fickert","year":"2006","unstructured":"Fickert P et al (2006) 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology 130(2):465\u2013481. doi: 10.1053\/j.gastro.2005.10.018","journal-title":"Gastroenterology"},{"issue":"2","key":"164_CR259","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.1840160213","volume":"16","author":"M Yoshikawa","year":"1992","unstructured":"Yoshikawa M et al (1992) Immunomodulatory effects of ursodeoxycholic acid on immune responses. Hepatology 16(2):358\u2013364. doi: 10.1002\/hep.1840160213","journal-title":"Hepatology"},{"issue":"4","key":"164_CR260","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/hep.510250423","volume":"25","author":"A Bergamini","year":"1997","unstructured":"Bergamini A et al (1997) Bile acids with differing hydrophilic\u2013hydrophobic properties do not influence cytokine production by human monocytes and murine Kupffer cells. Hepatology 25(4):927\u2013933. doi: 10.1002\/hep.510250423","journal-title":"Hepatology"},{"issue":"3","key":"164_CR261","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/hep.1840160317","volume":"16","author":"Y Calmus","year":"1992","unstructured":"Calmus Y et al (1992) Differential effects of chenodeoxycholic and ursodeoxycholic acids on interleukin 1, interleukin 6 and tumor necrosis factor-alpha production by monocytes. Hepatology 16(3):719\u2013723. doi: 10.1002\/hep.1840160317","journal-title":"Hepatology"},{"issue":"2","key":"164_CR262","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0016-5085(92)90855-S","volume":"103","author":"Y Calmus","year":"1992","unstructured":"Calmus Y et al (1992) Immunosuppressive properties of chenodeoxycholic and ursodeoxycholic acids in the mouse. Gastroenterology 103(2):617\u2013621","journal-title":"Gastroenterology"},{"issue":"4","key":"164_CR263","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.4049\/jimmunol.156.4.1601","volume":"156","author":"H Tanaka","year":"1996","unstructured":"Tanaka H et al (1996) Ligand-independent activation of the glucocorticoid receptor by ursodeoxycholic acid. Repression of IFN-gamma-induced MHC class II gene expression via a glucocorticoid receptor-dependent pathway. J Immunol 156(4):1601\u20131608","journal-title":"J Immunol"},{"issue":"1","key":"164_CR264","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1089-3261(03)00135-1","volume":"8","author":"G Paumgartner","year":"2004","unstructured":"Paumgartner G, Beuers U (2004) Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease. Clin Liver Dis 8(1):67\u201381. doi: 10.1016\/S1089-3261(03)00135-1 vi","journal-title":"Clin Liver Dis"},{"issue":"1","key":"164_CR265","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0168-8278(01)00092-7","volume":"35","author":"KN Lazaridis","year":"2001","unstructured":"Lazaridis KN, Gores GJ, Lindor KD (2001) Ursodeoxycholic acid \u2018mechanisms of action and clinical use in hepatobiliary disorders\u2019. J Hepatol 35(1):134\u2013146. doi: 10.1016\/S0168-8278(01)00092-7","journal-title":"J Hepatol"},{"issue":"8","key":"164_CR266","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1046\/j.1365-2036.1999.00596.x","volume":"13","author":"M Trauner","year":"1999","unstructured":"Trauner M, Graziadei IW (1999) Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases. Aliment Pharmacol Ther 13(8):979\u2013996. doi: 10.1046\/j.1365-2036.1999.00596.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"164_CR267","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840100102","volume":"10","author":"ER Dickson","year":"1989","unstructured":"Dickson ER et al (1989) Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 10(1):1\u20137. doi: 10.1002\/hep.1840100102","journal-title":"Hepatology"},{"issue":"1","key":"164_CR268","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0168-8278(03)00192-2","volume":"39","author":"RE Poupon","year":"2003","unstructured":"Poupon RE et al (2003) Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis. J Hepatol 39(1):12\u201316. doi: 10.1016\/S0168-8278(03)00192-2","journal-title":"J Hepatol"},{"issue":"4","key":"164_CR269","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0168-8278(00)80004-5","volume":"33","author":"M Kaya","year":"2000","unstructured":"Kaya M, Angulo P, Lindor KD (2000) Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system. J Hepatol 33(4):537\u2013542. doi: 10.1034\/j.1600-0641.2000.033004537.x","journal-title":"J Hepatol"},{"issue":"6","key":"164_CR270","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/hep.510290603","volume":"29","author":"RE Poupon","year":"1999","unstructured":"Poupon RE et al (1999) Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group. Hepatology 29(6):1668\u20131671. doi: 10.1002\/hep.510290603","journal-title":"Hepatology"},{"issue":"9","key":"164_CR271","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1111\/j.1572-0241.2006.00699.x","volume":"101","author":"PC Borg ter","year":"2006","unstructured":"ter Borg PC et al (2006) Prognosis of ursodeoxycholic acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients. Am J Gastroenterol 101(9):2044\u20132050. doi: 10.1111\/j.1572-0241.2006.00699.x","journal-title":"Am J Gastroenterol"},{"issue":"7\u20138","key":"164_CR272","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1023\/B:DDAS.0000037811.48575.da","volume":"49","author":"M Koulentaki","year":"2004","unstructured":"Koulentaki M et al (2004) Survival of anti-mitochondrial antibody-positive and -negative primary biliary cirrhosis patients on ursodeoxycholic acid treatment. Dig Dis Sci 49(7\u20138):1190\u20131195. doi: 10.1023\/B:DDAS.0000037811.48575.da","journal-title":"Dig Dis Sci"},{"issue":"2","key":"164_CR273","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/00365529709000190","volume":"32","author":"LS Eriksson","year":"1997","unstructured":"Eriksson LS et al (1997) Ursodeoxycholic acid treatment in patients with primary biliary cirrhosis. A Swedish multicentre, double-blind, randomized controlled study. Scand J Gastroenterol 32(2):179\u2013186. doi: 10.3109\/00365529709000190","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"164_CR274","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1572-0241.2004.04047.x","volume":"99","author":"B Combes","year":"2004","unstructured":"Combes B et al (2004) Prolonged follow-up of patients in the U.S. multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis. Am J Gastroenterol 99(2):264\u2013268. doi: 10.1111\/j.1572-0241.2004.04047.x","journal-title":"Am J Gastroenterol"},{"issue":"9184","key":"164_CR275","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(98)11293-X","volume":"354","author":"J Goulis","year":"1999","unstructured":"Goulis J, Leandro G, Burroughs AK (1999) Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis. Lancet 354(9184):1053\u20131060. doi: 10.1016\/S0140-6736(98)11293-X","journal-title":"Lancet"},{"key":"164_CR276","first-page":"CD000551","volume":"3","author":"Y Gong","year":"2008","unstructured":"Gong Y et al (2008) Ursodeoxycholic acid for primary biliary cirrhosis. Cochrane Database Syst Rev 3:CD000551","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"164_CR277","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1111\/j.1572-0241.2007.01235.x","volume":"102","author":"Y Gong","year":"2007","unstructured":"Gong Y et al (2007) Ursodeoxycholic acid for patients with primary biliary cirrhosis: an updated systematic review and meta-analysis of randomized clinical trials using Bayesian approach as sensitivity analyses. Am J Gastroenterol 102(8):1799\u20131807. doi: 10.1111\/j.1572-0241.2007.01235.x","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"164_CR278","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/j.1572-0241.2006.00634.x","volume":"101","author":"J Shi","year":"2006","unstructured":"Shi J et al (2006) Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials. Am J Gastroenterol 101(7):1529\u20131538. doi: 10.1111\/j.1572-0241.2006.00634.x","journal-title":"Am J Gastroenterol"},{"issue":"9204","key":"164_CR279","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(05)72401-6","volume":"355","author":"KD Lindor","year":"2000","unstructured":"Lindor KD et al (2000) Ursodeoxycholic acid for primary biliary cirrhosis. Lancet 355(9204):657\u2013658. doi: 10.1016\/S0140-6736(05)72401-6","journal-title":"Lancet"},{"key":"164_CR280","unstructured":"Beuers U et al (2009) EASL guideline cholestasis"},{"issue":"3","key":"164_CR281","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0168-8278(92)90065-W","volume":"15","author":"HC Mitchison","year":"1992","unstructured":"Mitchison HC et al (1992) A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results. J Hepatol 15(3):336\u2013344. doi: 10.1016\/0168-8278(92)90065-W","journal-title":"J Hepatol"},{"issue":"1","key":"164_CR282","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0168-8278(96)80327-8","volume":"25","author":"M Leuschner","year":"1996","unstructured":"Leuschner M et al (1996) Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis. J Hepatol 25(1):49\u201357. doi: 10.1016\/S0168-8278(96)80327-8","journal-title":"J Hepatol"},{"issue":"2","key":"164_CR283","first-page":"695","volume":"118","author":"F Arenas","year":"2008","unstructured":"Arenas F et al (2008) Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells. J Clin Invest 118(2):695\u2013709","journal-title":"J Clin Invest"},{"issue":"4","key":"164_CR284","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0016-5085(99)70351-3","volume":"117","author":"M Leuschner","year":"1999","unstructured":"Leuschner M et al (1999) Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial. Gastroenterology 117(4):918\u2013925. doi: 10.1016\/S0016-5085(99)70351-3","journal-title":"Gastroenterology"},{"issue":"4","key":"164_CR285","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0168-8278(00)80002-1","volume":"33","author":"P Angulo","year":"2000","unstructured":"Angulo P et al (2000) Magnetic resonance cholangiography in patients with biliary disease: its role in primary sclerosing cholangitis. J Hepatol 33(4):520\u2013527. doi: 10.1034\/j.1600-0641.2000.033004520.x","journal-title":"J Hepatol"},{"issue":"1","key":"164_CR286","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1053\/jhep.2003.50266","volume":"38","author":"W Hempfling","year":"2003","unstructured":"Hempfling W et al (2003) Pharmacokinetics and pharmacodynamic action of budesonide in early- and late-stage primary biliary cirrhosis. Hepatology 38(1):196\u2013202. doi: 10.1053\/jhep.2003.50266","journal-title":"Hepatology"},{"issue":"4","key":"164_CR287","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/hep.20646","volume":"41","author":"H Rautiainen","year":"2005","unstructured":"Rautiainen H et al (2005) Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: a three-year randomized trial. Hepatology 41(4):747\u2013752. doi: 10.1002\/hep.20646","journal-title":"Hepatology"},{"issue":"7","key":"164_CR288","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.cgh.2007.05.008","volume":"5","author":"EJ Heathcote","year":"2007","unstructured":"Heathcote EJ (2007) Diagnosis and management of cholestatic liver disease. Clin Gastroenterol Hepatol 5(7):776\u2013782. doi: 10.1016\/j.cgh.2007.05.008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"164_CR289","first-page":"168","volume":"39","author":"JA Talwalkar","year":"2005","unstructured":"Talwalkar JA et al (2005) Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid. J Clin Gastroenterol 39(2):168\u2013171","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"164_CR290","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000048854","volume":"64","author":"J Holtmeier","year":"2001","unstructured":"Holtmeier J, Leuschner U (2001) Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis. Digestion 64(3):137\u2013150. doi: 10.1159\/000048854","journal-title":"Digestion"},{"issue":"3","key":"164_CR291","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1055\/s-2005-916326","volume":"25","author":"JM Vierling","year":"2005","unstructured":"Vierling JM (2005) Future treatment options in PBC. Semin Liver Dis 25(3):347\u2013363. doi: 10.1055\/s-2005-916326","journal-title":"Semin Liver Dis"},{"issue":"6","key":"164_CR292","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/0016-5085(86)90183-6","volume":"91","author":"JH Hoofnagle","year":"1986","unstructured":"Hoofnagle JH et al (1986) Randomized trial of chlorambucil for primary biliary cirrhosis. Gastroenterology 91(6):1327\u20131334","journal-title":"Gastroenterology"},{"issue":"16","key":"164_CR293","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJM198504183121602","volume":"312","author":"ER Dickson","year":"1985","unstructured":"Dickson ER et al (1985) Trial of penicillamine in advanced primary biliary cirrhosis. N Engl J Med 312(16):1011\u20131015","journal-title":"N Engl J Med"},{"issue":"23","key":"164_CR294","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJM198612043152304","volume":"315","author":"MM Kaplan","year":"1986","unstructured":"Kaplan MM et al (1986) A prospective trial of colchicine for primary biliary cirrhosis. N Engl J Med 315(23):1448\u20131454","journal-title":"N Engl J Med"},{"issue":"5","key":"164_CR295","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1053\/jhep.2000.18663","volume":"32","author":"P Angulo","year":"2000","unstructured":"Angulo P et al (2000) Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid. Hepatology 32(5):897\u2013900. doi: 10.1053\/jhep.2000.18663","journal-title":"Hepatology"},{"issue":"10","key":"164_CR296","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1111\/j.1572-0241.2000.03220.x","volume":"95","author":"T Kurihara","year":"2000","unstructured":"Kurihara T et al (2000) Bezafibrate in the treatment of primary biliary cirrhosis: comparison with ursodeoxycholic acid. Am J Gastroenterol 95(10):2990\u20132992. doi: 10.1111\/j.1572-0241.2000.03220.x","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"164_CR297","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1872-034X.2007.00305.x","volume":"38","author":"S Iwasaki","year":"2008","unstructured":"Iwasaki S et al (2008) The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: a prospective, multicenter study. Hepatol Res 38(6):557\u2013564. doi: 10.1111\/j.1872-034X.2007.00305.x","journal-title":"Hepatol Res"},{"issue":"7","key":"164_CR298","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/j.1572-0241.2007.01200.x","volume":"102","author":"P Tandon","year":"2007","unstructured":"Tandon P et al (2007) The efficacy and safety of bile acid binding agents, opioid antagonists, or rifampin in the treatment of cholestasis-associated pruritus. Am J Gastroenterol 102(7):1528\u20131536. doi: 10.1111\/j.1572-0241.2007.01200.x","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"164_CR299","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/0016-5085(88)90442-8","volume":"94","author":"CN Ghent","year":"1988","unstructured":"Ghent CN, Carruthers SG (1988) Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial. Gastroenterology 94(2):488\u2013493","journal-title":"Gastroenterology"},{"issue":"2","key":"164_CR300","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/BF01300759","volume":"36","author":"A Podesta","year":"1991","unstructured":"Podesta A et al (1991) Treatment of pruritus of primary biliary cirrhosis with rifampin. Dig Dis Sci 36(2):216\u2013220. doi: 10.1007\/BF01300759","journal-title":"Dig Dis Sci"},{"issue":"6","key":"164_CR301","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/0016-5085(92)90335-V","volume":"102","author":"L Bachs","year":"1992","unstructured":"Bachs L et al (1992) Effects of long-term rifampicin administration in primary biliary cirrhosis. Gastroenterology 102(6):2077\u20132080","journal-title":"Gastroenterology"},{"issue":"2","key":"164_CR302","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/0016-5085(92)90102-5","volume":"102","author":"NV Bergasa","year":"1992","unstructured":"Bergasa NV et al (1992) A controlled trial of naloxone infusions for the pruritus of chronic cholestasis. Gastroenterology 102(2):544\u2013549","journal-title":"Gastroenterology"},{"issue":"3","key":"164_CR303","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.510270307","volume":"27","author":"NV Bergasa","year":"1998","unstructured":"Bergasa NV et al (1998) Open-label trial of oral nalmefene therapy for the pruritus of cholestasis. Hepatology 27(3):679\u2013684. doi: 10.1002\/hep.510270307","journal-title":"Hepatology"},{"issue":"6","key":"164_CR304","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0168-8278(02)00318-5","volume":"37","author":"R Terg","year":"2002","unstructured":"Terg R et al (2002) Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study. J Hepatol 37(6):717\u2013722. doi: 10.1016\/S0168-8278(02)00318-5","journal-title":"J Hepatol"},{"issue":"12","key":"164_CR305","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1111\/j.1572-0241.2003.08662.x","volume":"98","author":"J Browning","year":"2003","unstructured":"Browning J, Combes B, Mayo MJ (2003) Long-term efficacy of sertraline as a treatment for cholestatic pruritus in patients with primary biliary cirrhosis. Am J Gastroenterol 98(12):2736\u20132741. doi: 10.1111\/j.1572-0241.2003.08662.x","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"164_CR306","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/hep.21553","volume":"45","author":"MJ Mayo","year":"2007","unstructured":"Mayo MJ et al (2007) Sertraline as a first-line treatment for cholestatic pruritus. Hepatology 45(3):666\u2013674. doi: 10.1002\/hep.21553","journal-title":"Hepatology"},{"key":"164_CR307","first-page":"CD000551","volume":"1","author":"C Gluud","year":"2002","unstructured":"Gluud C, Christensen E (2002) Ursodeoxycholic acid for primary biliary irrhosis. Cochrane Database Syst Rev 1:CD000551","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"164_CR308","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1365-2036.2003.01398.x","volume":"17","author":"MI Prince","year":"2003","unstructured":"Prince MI et al (2003) Oral antioxidant supplementation for fatigue associated with primary biliary cirrhosis: results of a multicentre, randomized, placebo-controlled, cross-over trial. Aliment Pharmacol Ther 17(1):137\u2013143. doi: 10.1046\/j.1365-2036.2003.01398.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"164_CR309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/cs0990001","volume":"99","author":"MG Swain","year":"2000","unstructured":"Swain MG (2000) Fatigue in chronic disease. Clin Sci (Lond) 99(1):1\u20138. doi: 10.1042\/CS19990372","journal-title":"Clin Sci (Lond)"},{"issue":"6","key":"164_CR310","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/hep.20698","volume":"41","author":"JJ Theal","year":"2005","unstructured":"Theal JJ et al (2005) A randomized, controlled crossover trial of ondansetron in patients with primary biliary cirrhosis and fatigue. Hepatology 41(6):1305\u20131312. doi: 10.1002\/hep.20698","journal-title":"Hepatology"},{"key":"164_CR311","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-230X-4-13","volume":"4","author":"PC Borg ter","year":"2004","unstructured":"ter Borg PC et al (2004) Fluvoxamine for fatigue in primary biliary cirrhosis and primary sclerosing cholangitis: a randomised controlled trial. BMC Gastroenterol 4:13. doi: 10.1186\/1471-230X-4-13 ISRCTN88246634","journal-title":"BMC Gastroenterol"},{"issue":"11","key":"164_CR312","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s10620-006-9397-5","volume":"51","author":"JA Talwalkar","year":"2006","unstructured":"Talwalkar JA et al (2006) Fluoxetine for the treatment of fatigue in primary biliary cirrhosis: a randomized, double-blind controlled trial. Dig Dis Sci 51(11):1985\u20131991. doi: 10.1007\/s10620-006-9397-5","journal-title":"Dig Dis Sci"},{"issue":"1","key":"164_CR313","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/hep.21230","volume":"44","author":"JL Newton","year":"2006","unstructured":"Newton JL et al (2006) Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence. Hepatology 44(1):91\u201398. doi: 10.1002\/hep.21230","journal-title":"Hepatology"},{"issue":"4","key":"164_CR314","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2036.2006.03223.x","volume":"25","author":"DE Jones","year":"2007","unstructured":"Jones DE, Newton JL (2007) An open study of modafinil for the treatment of daytime somnolence and fatigue in primary biliary cirrhosis. Aliment Pharmacol Ther 25(4):471\u2013476","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"164_CR315","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1590-8658(03)00078-1","volume":"35","author":"E Solerio","year":"2003","unstructured":"Solerio E et al (2003) Osteoporosis: still a typical complication of primary biliary cirrhosis? Dig Liver Dis 35(5):339\u2013346. doi: 10.1016\/S1590-8658(03)00078-1","journal-title":"Dig Liver Dis"},{"issue":"6","key":"164_CR316","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1053\/j.gastro.2006.09.012","volume":"131","author":"M Solaymani-Dodaran","year":"2006","unstructured":"Solaymani-Dodaran M et al (2006) Fracture risk in people with primary biliary cirrhosis: a population-based cohort study. Gastroenterology 131(6):1752\u20131757. doi: 10.1053\/j.gastro.2006.09.012","journal-title":"Gastroenterology"},{"issue":"2","key":"164_CR317","first-page":"389","volume":"21","author":"KD Lindor","year":"1995","unstructured":"Lindor KD et al (1995) Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference? Hepatology 21(2):389\u2013392","journal-title":"Hepatology"},{"issue":"2","key":"164_CR318","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/gut.49.2.282","volume":"49","author":"J Newton","year":"2001","unstructured":"Newton J et al (2001) Osteoporosis in primary biliary cirrhosis revisited. Gut 49(2):282\u2013287. doi: 10.1136\/gut.49.2.282","journal-title":"Gut"},{"issue":"1","key":"164_CR319","first-page":"47","volume":"89","author":"JS Crippin","year":"1994","unstructured":"Crippin JS et al (1994) Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment. Am J Gastroenterol 89(1):47\u201350","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 1","key":"164_CR320","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/gut.50.suppl_1.i1","volume":"50","author":"JD Collier","year":"2002","unstructured":"Collier JD, Ninkovic M, Compston JE (2002) Guidelines on the management of osteoporosis associated with chronic liver disease. Gut 50(Suppl 1):i1\u2013i9. doi: 10.1136\/gut.50.suppl_1.i1","journal-title":"Gut"},{"issue":"3","key":"164_CR321","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0270-9139(94)90098-1","volume":"20","author":"M Camisasca","year":"1994","unstructured":"Camisasca M et al (1994) Parenteral calcitonin for metabolic bone disease associated with primary biliary cirrhosis. Hepatology 20(3):633\u2013637. doi: 10.1016\/0270-9139(94)90098-1","journal-title":"Hepatology"},{"issue":"3","key":"164_CR322","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1478-3231.1999.tb00034.x","volume":"19","author":"R Olsson","year":"1999","unstructured":"Olsson R et al (1999) Estrogen\u2013progestogen therapy for low bone mineral density in primary biliary cirrhosis. Liver 19(3):188\u2013192. doi: 10.1111\/j.1478-3231.1999.tb00034.x","journal-title":"Liver"},{"issue":"5","key":"164_CR323","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2036.2004.01890.x","volume":"19","author":"SP Pereira","year":"2004","unstructured":"Pereira SP et al (2004) Transdermal hormone replacement therapy improves vertebral bone density in primary biliary cirrhosis: results of a 1-year controlled trial. Aliment Pharmacol Ther 19(5):563\u2013570. doi: 10.1111\/j.1365-2036.2004.01890.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"164_CR324","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00001703-200312000-00001","volume":"15","author":"T Kocjan","year":"2003","unstructured":"Kocjan T, Prelevic GM (2003) Hormone replacement therapy update: who should we be prescribing this to now? Curr Opin Obstet Gynecol 15(6):459\u2013464. doi: 10.1097\/00001703-200312000-00001","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"7","key":"164_CR325","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","volume":"280","author":"S Hulley","year":"1998","unstructured":"Hulley S et al (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/progestin Replacement Study (HERS) Research Group. JAMA 280(7):605\u2013613. doi: 10.1001\/jama.280.7.605","journal-title":"JAMA"},{"issue":"3","key":"164_CR326","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"JE Rossouw","year":"2002","unstructured":"Rossouw JE et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women\u2019s Health Initiative randomized controlled trial. JAMA 288(3):321\u2013333. doi: 10.1001\/jama.288.3.321","journal-title":"JAMA"},{"issue":"6","key":"164_CR327","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0168-8278(00)80118-X","volume":"33","author":"KD Lindor","year":"2000","unstructured":"Lindor KD et al (2000) Etidronate for osteoporosis in primary biliary cirrhosis: a randomized trial. J Hepatol 33(6):878\u2013882. doi: 10.1016\/S0168-8278(00)80118-X","journal-title":"J Hepatol"},{"issue":"6","key":"164_CR328","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.dld.2007.02.005","volume":"39","author":"A Floreani","year":"2007","unstructured":"Floreani A et al (2007) A 4-year treatment with clodronate plus calcium and vitamin D supplements does not improve bone mass in primary biliary cirrhosis. Dig Liver Dis 39(6):544\u2013548. doi: 10.1016\/j.dld.2007.02.005","journal-title":"Dig Liver Dis"},{"issue":"4","key":"164_CR329","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.20866","volume":"42","author":"CO Zein","year":"2005","unstructured":"Zein CO et al (2005) Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebo-controlled trial. Hepatology 42(4):762\u2013771. doi: 10.1002\/hep.20866","journal-title":"Hepatology"},{"issue":"10","key":"164_CR330","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1111\/j.1572-0241.2003.07639.x","volume":"98","author":"N Guanabens","year":"2003","unstructured":"Guanabens N et al (2003) Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis. Am J Gastroenterol 98(10):2268\u20132274","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"164_CR331","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S1089-3261(03)00099-0","volume":"7","author":"GC MacQuillan","year":"2003","unstructured":"MacQuillan GC, Neuberger J (2003) Liver transplantation for primary biliary cirrhosis. Clin Liver Dis 7(4):941\u2013956. doi: 10.1016\/S1089-3261(03)00099-0 ix","journal-title":"Clin Liver Dis"},{"issue":"24","key":"164_CR332","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1056\/NEJMoa0810440","volume":"360","author":"GM Hirschfield","year":"2009","unstructured":"Hirschfield GM, Liu X et al (2009) Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 Variants. N Engl J Med 360(24):2544\u20132555","journal-title":"N Engl J Med"}],"container-title":["Seminars in Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-009-0164-5.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:30:42Z","timestamp":1685061042000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00281-009-0164-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,15]]},"references-count":332,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["164"],"URL":"https:\/\/doi.org\/10.1007\/s00281-009-0164-5","relation":{},"ISSN":["1863-2297","1863-2300"],"issn-type":[{"value":"1863-2297","type":"print"},{"value":"1863-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,15]]}}}